US20230024498A1 - Implantable stimulation power receiver, systems and methods - Google Patents
Implantable stimulation power receiver, systems and methods Download PDFInfo
- Publication number
- US20230024498A1 US20230024498A1 US17/661,705 US202217661705A US2023024498A1 US 20230024498 A1 US20230024498 A1 US 20230024498A1 US 202217661705 A US202217661705 A US 202217661705A US 2023024498 A1 US2023024498 A1 US 2023024498A1
- Authority
- US
- United States
- Prior art keywords
- stimulator
- coil
- recited
- turns
- coil turns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000638 stimulation Effects 0.000 title claims description 49
- 238000000034 method Methods 0.000 title description 5
- 239000000758 substrate Substances 0.000 claims abstract description 35
- 230000004044 response Effects 0.000 claims abstract description 14
- 230000005672 electromagnetic field Effects 0.000 claims abstract description 11
- 230000002232 neuromuscular Effects 0.000 claims abstract description 7
- 230000009975 flexible effect Effects 0.000 claims description 25
- 239000010949 copper Substances 0.000 claims description 10
- 210000003484 anatomy Anatomy 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 239000004642 Polyimide Substances 0.000 claims description 6
- 239000000560 biocompatible material Substances 0.000 claims description 6
- 229920001721 polyimide Polymers 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 239000007769 metal material Substances 0.000 claims 1
- 230000000926 neurological effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 description 24
- 210000001169 hypoglossal nerve Anatomy 0.000 description 19
- 210000003205 muscle Anatomy 0.000 description 18
- 208000001797 obstructive sleep apnea Diseases 0.000 description 17
- 238000004891 communication Methods 0.000 description 16
- 238000002567 electromyography Methods 0.000 description 13
- 230000007958 sleep Effects 0.000 description 12
- 238000010276 construction Methods 0.000 description 11
- 230000004936 stimulating effect Effects 0.000 description 10
- 239000010410 layer Substances 0.000 description 9
- 210000005036 nerve Anatomy 0.000 description 7
- 238000013461 design Methods 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 239000004020 conductor Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 230000004007 neuromodulation Effects 0.000 description 4
- 230000003071 parasitic effect Effects 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000005674 electromagnetic induction Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 2
- 206010041235 Snoring Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000012771 pancakes Nutrition 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- BSFZSQRJGZHMMV-UHFFFAOYSA-N 1,2,3-trichloro-5-phenylbenzene Chemical compound ClC1=C(Cl)C(Cl)=CC(C=2C=CC=CC=2)=C1 BSFZSQRJGZHMMV-UHFFFAOYSA-N 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101001034843 Mus musculus Interferon-induced transmembrane protein 1 Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- -1 for example Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000010329 laser etching Methods 0.000 description 1
- LQBJWKCYZGMFEV-UHFFFAOYSA-N lead tin Chemical compound [Sn].[Pb] LQBJWKCYZGMFEV-UHFFFAOYSA-N 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000008452 non REM sleep Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 230000008667 sleep stage Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36135—Control systems using physiological parameters
- A61N1/36139—Control systems using physiological parameters with automatic adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
- A61B5/7267—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0548—Oral electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36078—Inducing or controlling sleep or relaxation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/3611—Respiration control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
- A61N1/37229—Shape or location of the implanted or external antenna
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T11/00—2D [Two Dimensional] image generation
- G06T11/60—Editing figures and text; Combining figures or text
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/70—Determining position or orientation of objects or cameras
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V10/00—Arrangements for image or video recognition or understanding
- G06V10/40—Extraction of image or video features
- G06V10/42—Global feature extraction by analysis of the whole pattern, e.g. using frequency domain transformations or autocorrelation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V10/00—Arrangements for image or video recognition or understanding
- G06V10/40—Extraction of image or video features
- G06V10/60—Extraction of image or video features relating to illumination properties, e.g. using a reflectance or lighting model
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/10—Terrestrial scenes
- G06V20/13—Satellite images
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/10—Terrestrial scenes
- G06V20/176—Urban or other man-made structures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1113—Local tracking of patients, e.g. in a hospital or private home
- A61B5/1114—Tracking parts of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1116—Determining posture transitions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/394—Electromyography [EMG] specially adapted for electroglottography or electropalatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4538—Evaluating a particular part of the muscoloskeletal system or a particular medical condition
- A61B5/4542—Evaluating the mouth, e.g. the jaw
- A61B5/4552—Evaluating soft tissue within the mouth, e.g. gums or tongue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4812—Detecting sleep stages or cycles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4818—Sleep apnoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0072—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with application of electrical currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0507—Electrodes for the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36057—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for stimulating afferent nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
- A61N1/37282—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data characterised by communication with experts in remote locations using a network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10028—Range image; Depth image; 3D point clouds
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10032—Satellite or aerial image; Remote sensing
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10048—Infrared image
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/20—Special algorithmic details
- G06T2207/20212—Image combination
- G06T2207/20224—Image subtraction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/30—Assessment of water resources
Definitions
- an implantable electrical stimulation device and system is provided herein. More specifically, the present disclosure relates to an implantable stimulator including an antenna for powering the stimulator via an inductive power coupling with an external controller.
- the stimulator can be implemented in, or as a portion of, a system, method, and apparatus for stimulating the hypoglossal nerve to treat obstructive sleep apnea.
- Obstructive sleep apnea is the most common type of sleep apnea and is characterized by repeated episodes of complete or partial obstructions of the upper airway during sleep, despite the effort to breathe, and is usually associated with a reduction in blood oxygen saturation. Individuals with OSA are rarely aware of difficulty breathing, even upon awakening. It is often recognized as a problem by others who observe the individual during episodes or is suspected because of its effects on the body. OSA is commonly accompanied with snoring. OSA can be associated with symptoms during the daytime (e.g., excessive daytime sleepiness, decreased cognitive functions). Symptoms may be present for years or even decades without identification, during which time the individual may become conditioned to the daytime sleepiness and fatigue associated with significant levels of sleep disturbance. Individuals who generally sleep alone are often unaware of the condition, without a regular bed-partner to notice and make them aware of the signs.
- OSA Obstructive sleep apnea
- CPAP continuous positive airway pressure
- Neurostimulation therapy can be an alternative for patients who cannot use a continuous positive airway pressure device.
- One neurostimulation system senses respiration and deliver mild electrical stimulation to the hypoglossal nerve (HGN) in order to increase muscle tone at the back of the tongue so it will not collapse over the airway.
- HGN hypoglossal nerve
- the HGN innervates the tongue musculature. It provides motor control for the muscles of the tongue and helps with important voluntary and involuntary functions like swallowing, speaking, and mastication. Stimulating the HGN can restore the tone to key tongue muscles that, when relaxed, can lead to obstructive sleep apnea.
- Conventional HGN neurostimulation systems utilize stimulation leads implanted in the patient's neck/throat, with electrodes touching, e.g., a cuff electrode that surrounds the HGN or in close proximity to the HGN.
- the leads are connected via wire to a pulse generator implanted under the skin in the patient's chest. From time-to-time, the pulse generator is surgically accessed for battery changes.
- the system includes a handheld patient controller to allow it to be switched on before sleep.
- HGN neurostimulation therapy has proven to be an effective treatment for OSA, the bulk of the conventional systems and the degree of invasiveness in implanting, using, and maintaining the system is undesirable.
- a wireless implantable stimulator can comprise an antenna for producing an induced current in response to being disposed in an electromagnetic field.
- the antenna can comprise a substrate having an upper surface and a lower surface, an upper coil comprising a plurality of coil turns disposed on the upper surface of the substrate, and a lower coil comprising a plurality of coil turns disposed on the lower surface of the substrate.
- the upper and lower coils can be electrically connected to each other in parallel.
- FIG. 1 is a diagram illustrating an example configuration of an implantable stimulation system according to an aspect of the present disclosure.
- FIG. 2 is a schematic illustration of an implantable stimulator portion of an implantable stimulation system according to an aspect of the present disclosure.
- FIG. 3 is a section view taken generally along line 3 - 3 of FIG. 2 , illustrating an antenna portion of the implantable stimulator.
- FIGS. 4 - 6 are schematic illustrations depicting flexible properties of an implantable stimulator according to an aspect of the present disclosure.
- FIGS. 7 - 8 are schematic illustrations depicting an exemplary configuration of a lead portion of an implantable stimulator according to an aspect of the present disclosure.
- FIGS. 9 A- 9 B are schematic illustrations depicting an exemplary configuration of an antenna portion of an implantable stimulator according to an aspect of the present disclosure.
- FIGS. 10 A- 10 C are schematic illustrations depicting exemplary configurations of a power mat portion of an electrical stimulation system according to an aspect of the present invention
- the terms “a,” “an,” and “the” include at least one or more of the described element including combinations thereof unless otherwise indicated. Further, the terms “or” and “and” refer to “and/or” and combinations thereof unless otherwise indicated. By “substantially” is meant that the shape or configuration of the described element need not have the mathematically exact described shape or configuration of the described element but can have a shape or configuration that is recognizable by one skilled in the art as generally or approximately having the described shape or configuration of the described element. As used herein, “stimulate” or “modulate” in the context of neuromodulation includes stimulating or inhibiting neural activity.
- a “patient” as described herein includes a mammal, such as a human being.
- the present disclosure relates to an implantable electrical stimulation system 10 , which can be used to provide a variety of electrical therapies, including neuromodulation therapies such as nerve and/or muscle stimulation. Stimulation can induce excitatory or inhibitory neural or muscular activity. Such therapies can be used at various suitable sites within a patient's anatomy.
- the system 10 can be used to treat sleep disordered breathing (SDB) including obstructive sleep apnea (OSA) via neuromodulation of the hypoglossal nerve (HGN).
- SDB sleep disordered breathing
- OSA obstructive sleep apnea
- HGN hypoglossal nerve
- the system 10 can include implantable stimulator 20 and external controller 100 .
- Controller 100 can power stimulator 20 through electromagnetic induction.
- Stimulator 20 can include power receiver 30 with antenna 32 .
- Electrical current can be induced in antenna 32 when it is positioned above power mat 112 of controller 100 , in an electric field produced by power transmit antenna 112 .
- Antennas 112 and 32 can also facilitate communication between controller 100 and stimulator 20 , respectively. This power/communication link between stimulator 20 and controller 100 is shown generally by the arrow 70 in FIG. 1 .
- System 10 can also include a user interface 200 the form of a computer platform 202 running a custom application that enables communication with controller 100 wirelessly, as indicated generally by arrow 204 . This can be done, for example, using Bluetooth or WiFi radio communication.
- computer platform 202 is a smartphone.
- the type of computer platform 202 could, however, vary.
- the computer platform 202 can be a physician or patient platform.
- Each platform 202 can have an application or “app” installed thereon that is user specific, i.e., a patient app or a physician app.
- the physician platform would have the physician app installed, and the patient platform would have the patient app installed.
- the patient app can allow the patient to execute certain commands necessary for controlling operation of stimulator 20 , such as, for example, start/stop therapy, increase/decrease stimulation power or intensity, and select a stimulation program.
- the physician app can also allow the physician to modify stimulation settings, such as pulse settings (patterns, duration, waveforms, etc.), stimulation frequency, amplitude settings, and electrode configurations, closed-loop and open loop control settings and tuning parameters for the embedded software that controls therapy delivery during use.
- computer platform 202 can be connected (e.g., WiFi and/or LTE) to internet/cloud 208 , which facilitates communication 214 with remote or cloud-based server 216 .
- internet/cloud 208 which facilitates communication 214 with remote or cloud-based server 216 .
- controller 100 itself can also be internet connected (e.g., WiFi), as shown at 210 . This can also allow for the transfer of data between controller 100 and server 216 via internet 208 .
- system 10 can be configured to provide various communication paths between the system components.
- computer platform 202 being connected to controller 100 (see 204 ) and to internet 208 (see 206 ) can facilitate a communication path from remote server 216 (see 214 ) to stimulator 20 itself (see 70 ).
- a communication path between server 216 and stimulator 20 can also be established via WiFi link 210 of controller 100 .
- a physician communication path can be established via the internet connection 206 of the remotely located physician platform 202 .
- remote physician platform 202 can communicate with server 216 through internet connection 206 .
- Remote physician platform 202 can also communicate with controller 100 , either via internet connection 210 (when enabled) or through patient controller 202 .
- the therapeutic approach implemented with system 10 can involve implanting only stimulator 20 , leaving controller 100 as an external component to be used only during the application of therapy.
- stimulator 20 can be configured to be powered by controller 100 through electromagnetic induction.
- power mat 110 operated by control unit 120 , can be positioned external to the patient in the vicinity of stimulator 20 to position transmitting antenna 112 of the controller, located in the mat, close to receiving antenna 32 of the stimulator.
- the power mat 110 can be positioned on or sufficiently near the sleeping surface while the patient sleeps to maintain the position of the receiving antenna 32 within the target volume of the electromagnetic field generated by the power antenna 112 .
- system 10 can deliver therapy to improve SDB such as OSA, for example, by stimulating the HGN, for example, through a shorter, less invasive procedure.
- SDB such as OSA
- HGN HGN
- system 10 can deliver therapy to improve SDB such as OSA, for example, by stimulating the HGN, for example, through a shorter, less invasive procedure.
- the elimination of an on-board, implanted power source in favor of an inductive power scheme can eliminate the need for batteries and the associated battery changes over the patient's life.
- stimulator 20 can implement electromyography (EMG) electrodes for sensing neuromuscular responses to physiological needs of the patient during sleep.
- EMG electromyography
- Such sensing electrodes can continuously monitor physiological intrinsic EMG signals from the anterior lingual musculature.
- EMG sensing electrodes can be configured to detect neuromuscular responses from the genioglossus muscle, which is innervated by the HGN.
- Controller 100 can use transmitting antenna 112 for multiple purposes, for example: 1) to provide power to stimulator 20 during therapy sessions, and 2) to communicate with the stimulator.
- This communication can, for example, include programming, e.g., uploading software/firmware revisions to stimulator 20 , changing/adjusting stimulation settings and/or parameters, and adjusting parameters of control algorithms.
- Controller 100 can receive the programming, software/firmware, and settings/parameters through any of the communication paths described above, e.g., from user interface 200 or through direct WiFi internet connection, when available.
- the communication paths can also be used to download data from stimulator 20 , such as measured data regarding completed stimulation therapy sessions, to the controller 100 .
- the controller 100 can transmit the downloaded data to the user interface 200 , which can send/upload the data to server 216 via internet 208 .
- sensed EMG responses from the genioglossus muscle can allow closed-loop operation of the stimulator 20 while eliminating the need for a chest lead.
- the stimulator 20 can maintain stimulation synchronized with respiration, for example, while preserving the ability to detect and account for momentary obstruction.
- the stimulator 20 can also detect and respond to snoring, for example.
- a control algorithm can be implemented locally on stimulator 20 . This can be achieved, for example, by programming a control algorithm on an application-specific integrated circuit (ASIC) component of stimulator 20 (see below for the description of the stimulator electronics).
- ASIC application-specific integrated circuit
- stimulator 20 can record data related to the stimulation session including, for example, stimulation settings, EMG responses, respiration, sleep state including different stages of REM and non-REM sleep, etc.
- data related to the stimulation session including, for example, stimulation settings, EMG responses, respiration, sleep state including different stages of REM and non-REM sleep, etc.
- changes in phasic and tonic EMG activity of genioglossus muscle during inspiration can serve as a trigger for stimulation or changes in stimulation can be made based on changes in phasic and tonic EMG activity of the genioglossus muscle during inspiration or during different sleep stages.
- this recorded data can be uploaded to user interface 200 and to server 216 .
- the patient can be queried to use the interface 200 to log data regarding their perceived quality of sleep, which can also be uploaded to the server 216 .
- the server 216 can execute a software application to evaluate the recorded data to determine whether settings and control parameters can be adjusted to further optimize the stimulation therapy.
- the software application can, for example, include artificial intelligence (AI) models that, learn from recorded therapy sessions, how certain adjustments affect the therapeutic outcome for the patient. In this manner, through AI learning, the model can provide patient-specific optimized therapy.
- AI artificial intelligence
- the stimulator can have a variety of configurations, which can be tailored to the specific therapy being applied and/or to the anatomy at the site at which the stimulation therapy is applied.
- An example configuration of the stimulator 20 is illustrated in FIG. 2 .
- Stimulator 20 can include power receiver 30 , electronics package 50 , and stimulator lead 80 .
- Power receiver 30 can include a coiled receiver antenna 32 that is packaged in a protective biocompatible material and is operatively connected to the electronics package 50 and electronic components 52 mounted therein.
- the stimulator lead 80 is also operatively connected to the electronics package 50 , which controls the operation of the electrodes 82 .
- stimulator 20 includes pigtail connector 54 , which extends from electronics package 50 and can facilitate connecting stimulator lead 80 to the electronics package.
- Pigtail connector 54 can facilitate a detachable connection between electronics package 50 and stimulator lead 80 so that leads of different configurations can be connected to the electronics package. This can facilitate manufacturing of the stimulator lead 80 . This can also allow a physician to select a lead having a desired size and/or configuration.
- the stimulator lead 80 being separate from, and connectable to, the remainder of the stimulator 20 via the pigtail connector 54 , can facilitate implanting the lead separately.
- implanting the lead 80 can be much less invasive, allowing the lead to be placed via a small incision.
- An integrated design could necessitate a larger incision and also the need to handle and manipulate the entire stimulator 20 as a whole during the implantation process, which could complicate the lead placement, as the surgeon could have to work around the remainder of the stimulator 20 , e.g., the electronics package 50 and the antenna 32 .
- Stimulator lead 80 can be generally elongated and includes a plurality of electrodes 82 spaced along its length. Electrodes 82 can be electrically connected to electronics package 50 by conductors, such as wires, that are illustrated schematically at 84 by dashed lines in FIG. 2 .
- stimulator 20 has an eight-channel, eight electrode configuration, meaning that stimulator lead 80 includes eight electrodes 82 , each having its own dedicated channel.
- Stimulator 20 can be configured to have a greater number of channels or fewer channels. Additionally or alternatively, stimulator 20 can include more than one lead, again depending on the specific therapy and/or the targeted anatomical structure.
- each electrode 82 can be configured and utilized independently of the other electrodes. Because of this, all or some of electrodes 82 , whichever is determined to be most effective for a particular implementation, can be utilized during the application of stimulation therapy.
- Electrodes 82 can be utilized as stimulating electrodes or sensing electrodes. Stimulating electrodes can used to apply stimulation to a target anatomical structure, such as, for example, a nerve or muscle. Sensing electrodes can be used to detect and measure an EMG response, for example, from a neuromuscular structure associated with the target nerve.
- the target nerve can be the HGN and the associated muscle can be the genioglossus muscle.
- the stimulator can, however, be used to target other nerves and to measure physiological electrical signals from other anatomical structures, such as EMG responses, from other neuromuscular structures.
- electrodes 82 are arranged in two groups of four electrodes spaced along the length of lead 80 .
- One group of electrodes 82 can be positioned distally near an end of lead 80 and one group can be positioned proximally, between the distal group and electronics package 50 .
- the configuration of electrodes 82 can, however, vary.
- the stimulator can include a different number of electrodes (two or more), and/or the electrodes can be grouped, spaced, or otherwise arranged in different configurations along the length of the lead. As mentioned previously, the stimulator can also include any suitable number of leads (one or more).
- the identities of electrodes 82 as being stimulation electrodes or sensing electrodes can be determined by the manner in which they are controlled via electronics package 50 .
- the identities of electrodes 82 can be fixed. In a fixed implementation, certain ones of electrodes 82 can be assigned and used exclusively as stimulating electrodes and others can be assigned and used exclusively as sensing electrodes.
- the identities of electrodes 82 can be dynamic. In a dynamic implementation, electrodes 82 can be assigned and used as both stimulating and sensing electrodes. In further implementations, electrodes 82 can be implemented in combinations of fixed and variable identities.
- the electrodes can be positioned relative to structures, such as nerves and/or muscles for which both the application of stimulation energy and the sensing of an EMG response or other physiological electrical signal is desired. In these cases, some or all of the electrodes can be utilized as stimulating electrodes when stimulation at its location is desired, and as sensing electrodes when sensing at its location is desired. In other implementations of the stimulator, some electrodes can be positioned relative to structures for which only the application of stimulation energy is desired, and other electrodes might be positioned relative to structures for which only the sensing of EMG responses or other physiological signals is desired.
- the identities of electrodes 82 is configured in software settings, and requires no hardware configurations.
- the selectable configurations of electrodes 82 can be facilitated by electronic components 52 enclosed in electronics package 50 .
- Electronic components 52 are preferably implemented in an application-specific integrated circuit (ASIC).
- the electronic components 52 can, however, include one or more ASICs, discrete electronic components, and electrical connectors for connecting the electronic components to power receiver 30 and/or electrode lead 80 .
- the electronic components can, for example, include processing and memory components, e.g., microcomputers or computers-on-a-chip, charge storage devices (e.g., capacitors) for accumulating a charge and supplying stimulation power, and solid state switching devices for selecting the identities of the electrodes (e.g., anode, cathode, recording electrode) and modulating power supplied to the electrodes (e.g., pulse-width modulation (PWM) switches).
- processing and memory components e.g., microcomputers or computers-on-a-chip
- charge storage devices e.g., capacitors
- solid state switching devices for selecting the identities of the electrodes (e.g., anode, cathode, recording electrode) and modulating power supplied to the electrodes (e.g., pulse-width modulation (PWM) switches).
- PWM pulse-width modulation
- the stimulator 20 can have a generally soft/flexible construction. This soft/flexible construction can apply to lead 80 , power receiver 30 , or both the lead and the power receiver.
- power receiver 30 and lead 80 can have a flexible configuration that allows either or both structures to bend or flex, which facilitates implantation compatibility with a variety of anatomical structures.
- Power receiver 30 can be generally flat and planar in configuration, and can bend in directions transverse to its plane which, as shown in FIGS. 4 - 6 , is the X-Y plane. Power receiver 30 can thus bend in the Z-direction as shown in dashed lines at 30′ in the Figures.
- Lead 80 can be generally elongated in configuration and can extend axially, along the X-axis as shown in FIGS. 4 - 6 . Lead 80 can bend in multiple directions relative to that plane, i.e., in the direction of one or both of the Y-direction and Z-direction, as shown in dashed lines at 80′ in the figures.
- Electrodes 82 and the conductors 84 that connect the electrodes to the electronics package 50 can be encased and supported in a covering 86 .
- Covering 86 can be formed of a biocompatible material, such as silicone and various suitable polymers, and can be configured to leave exposed electrodes 82 or portions thereof. Covering 86 can be formed, for example, in the aforementioned insert molded covering of the stimulator 20 structure.
- antenna 32 can be formed on a soft substrate so as to be flexible and conform to the anatomy at the site of implantation.
- power receiver 30 can have a flexible printed circuit board (PCB) construction in which antenna 32 is etched from a thin layer of conductive metal laminated on a substrate 38 (see FIG. 3 ) constructed of a flexible material, such as a polymer.
- the substrate can be a polyimide material and the conductive metal can be copper.
- Other flexible PCB constructions can be implemented.
- Antenna 32 can be encased and supported in covering 48 .
- Covering 48 can be formed of a biocompatible material, such as silicone, epoxy and various suitable polymers. Covering 48 can be formed, for example, in the aforementioned insert molded covering of the entire stimulator 20 structure.
- the flexible PCB of power receiver 30 can extend into electronics package 50 and can be configured to mount the electronic components 52 .
- the PCB can also be configured to interface conductors 84 of lead 80 , and/or to form portions of the lead itself.
- power receiver 30 , electronics package 50 , and lead 80 (or portions thereof) can be encased in the biocompatible material (e.g., silicone, epoxy and various suitable polymers) simultaneously.
- the lead can also be configured to maintain a shape to which it is formed. This feature can, for example, be facilitated by conductors 84 that connect electrodes 82 to electronics package 50 or by an additional internal shape-maintaining (e.g., metal) support structure (not shown) that extends along its length.
- metal conductors 84 or the support structure can be selected or otherwise configured to possess physical properties, such as malleability/ductility, that allow the lead to be manipulated three dimensionally (3-D) into a desired shape or have a pre-determined bias and to maintain that shape or bias once formed.
- the lead can be biased to have a certain shape that is created, for example, by heat shaping, material shaping or using other methods of manufacturing a biased lead.
- FIGS. 7 - 8 illustrate one such 3-D shape to which the lead 80 can be formed.
- the example configuration of FIGS. 7 - 8 shows the lead 80 formed three-dimensionally in a generally U-Shape or omega-shape, as shown in the plan view of FIG. 7 , with an additional or alternative bend depth-wise as shown in FIG. 8 .
- This particular 3-D configuration can be implemented to position the electrodes 82 at different positions along the HGN, where the stimulator is configured to treat SDB, such as OSA, for example.
- the configuration of the lead 80 in FIGS. 7 and 8 can allow for the right and left electrodes 82 (as viewed in FIG. 7 ) to be placed in very close proximity to the HGN branches.
- the right and left electrodes 82 in an implanted configuration can extend along the posterior-anterior course of the HGN, placing the electrodes at or near the location of the branch points, such as distal branch points from the main trunk. This placement allows for direct electrical activation of a single branch or branches as needed for control of the posterior airway.
- neurostimulation system 10 can be configured to stimulate bilaterally or unilaterally as needed without unnecessary or unwanted stimulation of surrounding structures. Because of the 3-D biased nature of the lead 80 and the synchronous manner in which the anterior lingual muscle move, additional anchoring structures may be unnecessary.
- the inferior bend of the intermediate portion of the lead relative to the left and right electrode sets 82 when the stimulator is fully deployed can allow for force to be exerted against the genioglossus muscle by the lead, since the genioglossus muscle has a convex shape (when viewed inferiorly) to allow for better contact between the electrode sets and the genioglossus muscle
- the power receiver is designed with the goal of delivering maximum power to the stimulator from a given external magnetic field.
- power receiver and receiving antenna have a unique configuration designed to adhere to several criteria for stimulator.
- the criteria depend, of course, on the intended therapeutic use of the system and the configuration resulting therefrom.
- the criteria set forth below are specific to an example configuration of system for treating SDB including OSA via neuromodulation of the HGN:
- the stimulator 20 operates within the guidelines for maximum permissible magnetic field exposure as recommended in IEEE Standard C95.1-2005 (Reference 3).
- the receiving antenna 32 allows for near continuous power consumption (10-30 milliwatts (mW)) from the stimulator 20 .
- the receiving antenna operates at a frequency ranging from 100 kHz to 2.4 GHz ISM (industrial, scientific, medical band of the radiofrequency spectrum). In one particular implementation, frequencies of 6.78 MHz or 13.56 MHz were used.
- the receiving antenna 32 has a diameter of 2-3 cm. and be as thin as possible to maintain flexibility.
- the stimulator 20 is small enough for minimally invasive subcutaneous implantation within the soft tissue of the sub-maxillary neck.
- the stimulator 20 maintains a soft, flexible design so that it can be manipulated to conform to the anatomy of the patient.
- Other stimulation therapies or implementations of the implantable stimulation system 10 can cause some or all of these criteria to be changed or adjusted, and also for certain criteria to be added or removed.
- receiving antenna 32 can have a double-layer, flat, “pancake” configuration.
- antenna 32 can have a flexible PCB construction in which first or upper/top antenna coil 34 is formed on a first or upper/top side of substrate 38 and second or lower/bottom antenna coil 36 is formed on a second or lower/bottom side of the substrate.
- Substrate 38 can be a thin (e.g., 1 to 3 mil) polyimide layer and coils 34 , 36 can be etched from thin layers of copper or gold (e.g., 1 oz./ft 2 ⁇ 1.4 mil) laminated onto substrate 38 .
- PCB 38 can also support electronic components 52 in electronics package 50 .
- the maximum achievable delivered power is approximately 10-30 mW at 6.78 MHz frequency.
- These power requirements were chosen based on the estimated requirements for components 52 of electronics package 50 , the estimated maximum stimulation parameters, and pre-clinical studies, while also including a safety factor to allow for capacitor charging and to provide transitional power.
- Transitional power can be provided via a variety of components, such as capacitors, supercapacitors, ultracapacitors, or even a rechargeable power source, such as a battery. Continuous power during patient movement, especially at the high end of power ratios and/or when coupling is not ideal. The transitional power source helps ensure complete, continuous operation of the stimulator 20 , even during patient movement.
- an antenna in operation, can be susceptible to power losses due to substrate losses and parasitic capacitance between coils 34 , 36 and between the individual coil turns. Substrate losses occur due to eddy currents in the substrate due to the non-zero resistance of the substrate material. Parasitic capacitance occurs when these adjacent components are at different voltages, creating an electric field that results in a stored charge. All circuit elements possess this internal capacitance, which can cause their behavior to depart from that of “ideal” circuit elements.
- antenna 32 can implement a unique two-layer, pancake style coil configuration in which coils 34 , 36 are configured in parallel.
- coils 34 , 36 can generate an equal or substantially equal induced voltage potential when subjected to an electromagnetic field. This can help to equalize the voltage of coils 34 , 36 during use, and has been shown to significantly reduce the parasitic capacitance of antenna 32 .
- top and bottom coils 34 , 36 are shorted together within each turn. This design has been found to retain the benefit of lower series resistance in a two-layer design while, at the same time, greatly reducing the parasitic capacitance and producing a high maximum power output.
- Each coil can include a plurality of coil windings or turns and can be characterized by the following properties: number of turns (N), outside diameter (OD), coil pitch (P), trace width (W), trace thickness (T), and coil spacing (S). These properties are measured as follows:
- the OD is the diameter of coil 34 , 36 measured across the coil between outer edges of outermost turn 40 .
- the coil pitch P is the spacing between turns 40 measured between any two adjacent turns.
- the coil width W is the width of each coil turn 40 .
- the trace thickness T is the thickness of turns 40 , which is determined by the thickness of the conductive (Cu) layers laminated onto substrate 38 in the PCB construction.
- the coil spacing S is the distance between coils 34 , 36 , which is determined by the thickness of substrate 38 in the PCB construction.
- PCB substrate 38 is a 2 mil polyimide layer and coils 34 , 36 are etched from 1 . 4 mil copper laminated onto the substrate.
- the parallel coil configuration of the antenna 32 results from electrically connecting the turns 40 of the coils 34 , 36 through substrate 38 .
- These connections can be in the form of electrically conductive connectors illustrated at 42 in FIGS. 9 A and 9 B .
- Connectors 42 between the turns 40 can, for example, be formed by drilling or laser etching holes through the PCB structure, e.g., through substrate 38 and turns 40 of the upper and lower coils 34 , 36 , and plating or filling the holes with a metal, such as plated copper/gold or melted and/or flowed tin-lead, for example, to electrically connect the turns on the opposite surfaces of the substrate.
- the connectors could also be formed mechanically, e.g., pins or rivets.
- Coils 34 , 36 of antenna 32 have a unique configuration that allows for their parallel interconnection.
- turns 40 are circular, each having a fixed diameter with closely spaced ends. This is opposed to a traditional coil configuration in which the diameter of the turns varies continuously in a spiral that decreases progressively from outside to inside.
- links 44 can extend diagonally between adjacent turns 40 of upper coil 34 .
- Links 44 can be formed as portions of the copper layer, for example, laminated onto substrate 38 , and therefore can be formed coextensively with turns 40 of upper coil 34 as one continuous conductive (Cu) strip.
- Upper coil 34 can therefore be configured as a continuous coil having decreasing diameter from outside to inside and can therefore function as a spirally configured coil.
- turns 40 can also be circular, each having a fixed diameter with closely spaced ends. There can be no links connecting adjacent turns 40 of lower coil 36 .
- terminals 46 can be formed—one connected to a terminal end of the innermost turn of the lower coil, and one connected to a terminal end of the outermost turn of the lower coil. Terminals 46 can be connected to innermost turn 40 and can extend in the space between the ends of the remaining turns.
- turns 40 of upper and lower coils 34 , 36 can be interconnected at each of connectors 42 .
- the links 44 interconnecting the adjacent turns 40 of the upper coil 34 can also interconnect the adjacent turns of lower coil 36 .
- turns 40 of the lower coil 36 also can be arranged in a continuous coiled configuration through connectors 42 and links 44 .
- Lower coil 36 therefore can be configured as a continuous coil having decreasing diameter from outside to inside and can therefore function as a spirally configured coil.
- Terminals 46 can be electrically connected to both upper coil 34 and lower coil 36 through connectors 42 .
- the terminal ends from which terminals 46 extend can be radially opposite ends of inner and outer turns 40 .
- terminal 46 of innermost turn 40 is connected to a first end of the turn, on a first side of the space between the opposite ends of the turns; whereas the terminal of outermost turn 40 is connected to an opposite second end of the turn, on an opposite second side of the space between the opposite ends of the turns.
- the performance of the antenna can depend on the properties listed above.
- Example 1 Example 2 Example 3 Example 4 Outer Diameter (OD) 30 mm 30 mm 30 mm 26 mm # Turns (N) 12 10 8 10 Coil Pitch (P) 1.0 mm 1.0 mm 1.0 mm 1.0 mm Trace Width (W) 0.5 mm 0.5 mm 0.5 mm 0.5 mm 0.5 mm Trace Thickness (T) 1.4 mil 1.4 mil 1.4 mil 1.4 mil Coil Spacing (S) 2 mil 2 mil 2 mil 2 mil Max. Power Delivery 32.0 mW 39.4 mW 43.7 mW 23.3 mW
- the external controller 100 can have two components: power mat 110 and bedside control unit 120 .
- Control unit 120 can be connected to power mat 110 by wire, for example, and is designed to be placed bedside, e.g., on a nightstand.
- the control unit can include a user interface, e.g., buttons, knobs, touchscreen, etc., to allow the user to control operation of the system when using the system in bed.
- Power mat 110 can be designed to be placed on the sleeping surface, such as a bed mattress, and therefore can be configured to have the form of a pad, e.g., a thin, flat, soft, flexible and non-slip configuration.
- Power mat 110 supports one or more wireless power transmit coils 112 in or on a flexible or semi-flexible surface 114 .
- Power mat 110 can be positioned on the sleeping surface so that a lower edge 116 of the mat corresponds approximately to the position of the patient's shoulders while sleeping.
- the shape and size of the power mat 110 can correspond, for example, to that of a pillow, such as a queen size pillow.
- Control unit 120 can excite power transmit coils 112 to generate an electromagnetic field.
- External controller 100 can utilize transmit coils 112 in power mat 110 to provide tethered wireless power transfer to stimulator 20 by way of receiving antenna 32 through electromagnetic induction.
- antenna 32 of stimulator 20 can be positioned within the electromagnetic field produced by transmit coils 112 of power mat 110 .
- the shape of the field can be tailored through the configuration of the coils 112 to provide a field that is optimized for powering the stimulator 20 through various sleeping positions.
- the field can be configured extend horizontally (as viewed in FIGS. 10 A-C ) between the coils 112 , so that the stimulator 20 can be powered any time it is positioned within the vertical bounds of the horizontally extending field.
- electrodes 82 can be utilized as stimulating electrodes for applying electrical stimulation to nerves or muscles, for example; as EMG sensing electrodes, for example, for detecting a neuromuscular response, to the application of electrical stimulation; or as both stimulation and sensing electrodes at different times during the application of stimulation therapy.
- external controller 100 can also provide a data link for facilitating two-way communication between the controller and the stimulator. While powering the stimulator, controller 100 can simultaneously provide a wireless data signal that is used to program the stimulator with settings, such as electrode assignments and stimulation parameters, and also retrieve stored data from the stimulator, such as triggered stimulation events, measured EMG responses or other electrical physiological signals, current values, electrode impedances, and data related to the wireless power transfer between controller 100 and stimulator 20 .
- the stimulator 20 can monitor the impedance and/or voltage of the stimulator antenna 32 so that the power supplied to the stimulator can be calculated. This can be provided as feedback to the controller 100 that allows the controller to adjust the current supplied to the power transmit coils 112 .
- the controller 100 can control the power delivered to the stimulator so as to remain within the standards/requirements set forth above. At the same time, the feedback can also facilitate increasing the current supplied to the power transmit coils 112 so that adequate power transfer to the stimulator 20 is maintained, again within the prescribed limits. In this manner, the controller 100 can implement closed-loop control to optimize the power supplied to the stimulator 20 .
- the operation of the controller 100 can be controlled through the user interface 200 , which allows the user, e.g., the patient, physician or other caretaker, to control aspects of the operation of the implantable stimulation system 10 .
- the control can be local, e.g., by the patient using a user interface of the control unit 120 or the patient user interface 200 , or remote, e.g., by the physician through internet/cloud 208 .
- the control unit 120 can have a small footprint and power mat 110 can be flexible in design so that external controller 100 is small, discreet, and portable for travel purposes.
- power mat 110 can have a large enough footprint to allow patient movement while still maintaining the ability to transmit power to stimulator 20 .
- external controller 100 does produce electromagnetic radiation at a level that falls outside the guidelines for maximum permissible magnetic field exposure as recommended in IEEE Standard C95.1-2005 (Reference 3).
- Example transmit coil configurations that can be implemented in power mat 110 are illustrated in FIGS. 10 A- 10 C .
- These example transmit coil configurations can be implemented with a flex circuit design, i.e., the coils can be formed (e.g., etched) from a conductive metal (e.g., copper or gold) laminated on a flexible substrate (e.g., polyimide).
- the examples of FIGS. 10 A- 10 C illustrate the overall shape of transmit coils 112 without showing the individual turns of the transmit coils. This is because the properties of the transmit coils 112 , e.g., the number of turns, coil pitch/spacing, trace width, etc. is not limited, as can be the case with coils 34 , 36 of antenna 32 .
- Antenna coils 34 , 36 can be tailored specifically for maximum induced power generation due to the small footprint limitations of antenna 32 of stimulator 20 .
- Power mat 110 can be larger in comparison and transmit coils 112 can be free to be configured to produce a magnetic field that can be limited only by requiring a level that falls within the IEEE magnetic field exposure guidelines mentioned previously.
- transmit coils 112 can be configured to maximize the space or volume that the magnetic field covers so as to allow for variations in the patient position during sleep. This can give the system the ability to continuously power the stimulator through a variety of sleeping positions throughout the night.
- FIG. 10 A shows a twelve coil example configuration of transmit coils 112 ;
- FIG. 10 B shows a two coil example configuration of transmit coils; and
- FIG. 100 shows a four coil example configuration of transmit coils.
- experimental testing showed that transmit coils 112 are capable of meeting the system power requirements, within the IEEE exposure guidelines, while allowing for consistent power transfer to the antenna 32 over an effective volume of approximately 32 ⁇ 76 ⁇ 25 cm (L ⁇ W ⁇ H), which was found to be sufficient to cover the patient during a normal sleep cycle.
- the twelve coil configuration of transmit coils 112 in FIG. 10 A can allow for dynamic control of the magnetic field produced by the power mat 110 .
- a determination can be made as to which coil(s) of the twelve coil configuration are effectuating the power coupling between the external controller and the stimulator.
- the external controller 100 can power only those coils necessary to power stimulator 20 , given the current position of the patient relative to power mat 110 .
- the stimulator can detect any decrease in power transmission, which can trigger a reassessment and the selection of different coil(s). This configuration can thus be self-tuning, on-the-fly to maximize the electromagnetic field produced by the power mat 110 in the area of the antenna 32 .
- the two coil configuration of the transmit coils 112 in FIG. 10 B can be static power coils that produce a continuous electromagnetic field around power mat 110 .
- This configuration can be tuned to maximize the electromagnetic field strength in the largest possible volume so that power transmission is maximized throughout a wide variety of patient positions.
- power mat 110 can have a flexible construction facilitated by a flexible circuit construction of transmit coils 112 housed within a flexible cover, such as, for example, soft plastic, rubber, fabric, etc.
- Transmit coils 112 can, for example, have a flexible PCB construction similar to antenna 32 of stimulator 20 .
- transmit coils 112 can be constructed as a single layer flexible PCB, with conductive traces etched from copper, for example, laminated on a polyimide, for example, substrate.
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 16/865,541, filed May 4, 2020, which claims the benefit of U.S. Provisional Application No. 62/841,978, filed May 2, 2019, the disclosures of which are hereby incorporated by reference in their entireties.
- An implantable electrical stimulation device and system is provided herein. More specifically, the present disclosure relates to an implantable stimulator including an antenna for powering the stimulator via an inductive power coupling with an external controller. In one example, the stimulator can be implemented in, or as a portion of, a system, method, and apparatus for stimulating the hypoglossal nerve to treat obstructive sleep apnea.
- Obstructive sleep apnea (OSA) is the most common type of sleep apnea and is characterized by repeated episodes of complete or partial obstructions of the upper airway during sleep, despite the effort to breathe, and is usually associated with a reduction in blood oxygen saturation. Individuals with OSA are rarely aware of difficulty breathing, even upon awakening. It is often recognized as a problem by others who observe the individual during episodes or is suspected because of its effects on the body. OSA is commonly accompanied with snoring. OSA can be associated with symptoms during the daytime (e.g., excessive daytime sleepiness, decreased cognitive functions). Symptoms may be present for years or even decades without identification, during which time the individual may become conditioned to the daytime sleepiness and fatigue associated with significant levels of sleep disturbance. Individuals who generally sleep alone are often unaware of the condition, without a regular bed-partner to notice and make them aware of the signs.
- The most widely used current therapeutic intervention for treating OSA is positive airway pressure whereby a breathing machine pumps a controlled stream of air through a mask worn over the nose, mouth, or both. The additional pressure holds open the relaxed muscles. There are several mechanisms for treating OSA with positive airway pressure therapy. The most common treatment involves the use of continuous positive airway pressure (CPAP) machines. CPAP machines are worn by the OSA patient at nighttime during sleep, with the patient wearing a mask connected by hose to an air pump that maintains positive airway pressure.
- Neurostimulation therapy can be an alternative for patients who cannot use a continuous positive airway pressure device. One neurostimulation system senses respiration and deliver mild electrical stimulation to the hypoglossal nerve (HGN) in order to increase muscle tone at the back of the tongue so it will not collapse over the airway. The HGN innervates the tongue musculature. It provides motor control for the muscles of the tongue and helps with important voluntary and involuntary functions like swallowing, speaking, and mastication. Stimulating the HGN can restore the tone to key tongue muscles that, when relaxed, can lead to obstructive sleep apnea.
- Conventional HGN neurostimulation systems utilize stimulation leads implanted in the patient's neck/throat, with electrodes touching, e.g., a cuff electrode that surrounds the HGN or in close proximity to the HGN. The leads are connected via wire to a pulse generator implanted under the skin in the patient's chest. From time-to-time, the pulse generator is surgically accessed for battery changes. The system includes a handheld patient controller to allow it to be switched on before sleep.
- While HGN neurostimulation therapy has proven to be an effective treatment for OSA, the bulk of the conventional systems and the degree of invasiveness in implanting, using, and maintaining the system is undesirable.
- In an aspect, a wireless implantable stimulator is provided. The stimulator can comprise an antenna for producing an induced current in response to being disposed in an electromagnetic field. The antenna can comprise a substrate having an upper surface and a lower surface, an upper coil comprising a plurality of coil turns disposed on the upper surface of the substrate, and a lower coil comprising a plurality of coil turns disposed on the lower surface of the substrate. The upper and lower coils can be electrically connected to each other in parallel.
-
FIG. 1 is a diagram illustrating an example configuration of an implantable stimulation system according to an aspect of the present disclosure. -
FIG. 2 is a schematic illustration of an implantable stimulator portion of an implantable stimulation system according to an aspect of the present disclosure. -
FIG. 3 is a section view taken generally along line 3-3 ofFIG. 2 , illustrating an antenna portion of the implantable stimulator. -
FIGS. 4-6 are schematic illustrations depicting flexible properties of an implantable stimulator according to an aspect of the present disclosure. -
FIGS. 7-8 are schematic illustrations depicting an exemplary configuration of a lead portion of an implantable stimulator according to an aspect of the present disclosure. -
FIGS. 9A-9B are schematic illustrations depicting an exemplary configuration of an antenna portion of an implantable stimulator according to an aspect of the present disclosure. -
FIGS. 10A-10C are schematic illustrations depicting exemplary configurations of a power mat portion of an electrical stimulation system according to an aspect of the present invention - As used herein with respect to a described element, the terms “a,” “an,” and “the” include at least one or more of the described element including combinations thereof unless otherwise indicated. Further, the terms “or” and “and” refer to “and/or” and combinations thereof unless otherwise indicated. By “substantially” is meant that the shape or configuration of the described element need not have the mathematically exact described shape or configuration of the described element but can have a shape or configuration that is recognizable by one skilled in the art as generally or approximately having the described shape or configuration of the described element. As used herein, “stimulate” or “modulate” in the context of neuromodulation includes stimulating or inhibiting neural activity. A “patient” as described herein includes a mammal, such as a human being.
- The present disclosure relates to an implantable
electrical stimulation system 10, which can be used to provide a variety of electrical therapies, including neuromodulation therapies such as nerve and/or muscle stimulation. Stimulation can induce excitatory or inhibitory neural or muscular activity. Such therapies can be used at various suitable sites within a patient's anatomy. In one example implementation, thesystem 10 can be used to treat sleep disordered breathing (SDB) including obstructive sleep apnea (OSA) via neuromodulation of the hypoglossal nerve (HGN). - Referring to
FIG. 1 , thesystem 10 can includeimplantable stimulator 20 andexternal controller 100.Controller 100 can powerstimulator 20 through electromagnetic induction.Stimulator 20 can includepower receiver 30 withantenna 32. Electrical current can be induced inantenna 32 when it is positioned abovepower mat 112 ofcontroller 100, in an electric field produced bypower transmit antenna 112.Antennas controller 100 andstimulator 20, respectively. This power/communication link betweenstimulator 20 andcontroller 100 is shown generally by thearrow 70 inFIG. 1 . -
System 10 can also include auser interface 200 the form of acomputer platform 202 running a custom application that enables communication withcontroller 100 wirelessly, as indicated generally byarrow 204. This can be done, for example, using Bluetooth or WiFi radio communication. In the example configuration ofFIG. 1 ,computer platform 202 is a smartphone. The type ofcomputer platform 202 could, however, vary. For example, thecomputer platform 202 can be a physician or patient platform. Eachplatform 202 can have an application or “app” installed thereon that is user specific, i.e., a patient app or a physician app. The physician platform would have the physician app installed, and the patient platform would have the patient app installed. The patient app can allow the patient to execute certain commands necessary for controlling operation ofstimulator 20, such as, for example, start/stop therapy, increase/decrease stimulation power or intensity, and select a stimulation program. In addition to the controls afforded the patient, the physician app can also allow the physician to modify stimulation settings, such as pulse settings (patterns, duration, waveforms, etc.), stimulation frequency, amplitude settings, and electrode configurations, closed-loop and open loop control settings and tuning parameters for the embedded software that controls therapy delivery during use. - As indicated generally by
arrow 206,computer platform 202 can be connected (e.g., WiFi and/or LTE) to internet/cloud 208, which facilitatescommunication 214 with remote or cloud-basedserver 216. This allows for the transfer of data betweenserver 216 andcomputer platform 202 viainternet 208. Additionally,controller 100 itself can also be internet connected (e.g., WiFi), as shown at 210. This can also allow for the transfer of data betweencontroller 100 andserver 216 viainternet 208. - As shown in
FIG. 1 and described above,system 10 can be configured to provide various communication paths between the system components. For example,computer platform 202 being connected to controller 100 (see 204) and to internet 208 (see 206) can facilitate a communication path from remote server 216 (see 214) tostimulator 20 itself (see 70). A communication path betweenserver 216 andstimulator 20 can also be established viaWiFi link 210 ofcontroller 100. - Additionally, recognizing that the physician may be remote from the patient, a physician communication path can be established via the
internet connection 206 of the remotely locatedphysician platform 202. Through this connection,remote physician platform 202 can communicate withserver 216 throughinternet connection 206.Remote physician platform 202 can also communicate withcontroller 100, either via internet connection 210 (when enabled) or throughpatient controller 202. - In addition to facilitating local control of system, e.g., controller and stimulator, the various communication paths described above can also enable:
- Distributing from
server 216 software/firmware updates for thecomputer platform 202,controller 100, and/orstimulator 20. - Downloading from
server 216 therapy settings/parameters to be implemented bycomputer platform 202,controller 100, and/orstimulator 20. - Facilitating therapy setting/parameter adjustments/algorithm adjustments by a remotely located physician.
- Uploading data recorded during therapy sessions.
- Maintaining coherency in the settings/parameters by distributing changes and adjustments throughout the system components.
- The therapeutic approach implemented with
system 10 can involve implanting onlystimulator 20, leavingcontroller 100 as an external component to be used only during the application of therapy. To facilitate this, stimulator 20 can be configured to be powered bycontroller 100 through electromagnetic induction. In operation,power mat 110, operated bycontrol unit 120, can be positioned external to the patient in the vicinity ofstimulator 20 to position transmittingantenna 112 of the controller, located in the mat, close to receivingantenna 32 of the stimulator. In the implementation where thesystem 10 is used to treat OSA, thepower mat 110 can be positioned on or sufficiently near the sleeping surface while the patient sleeps to maintain the position of the receivingantenna 32 within the target volume of the electromagnetic field generated by thepower antenna 112. - Through this approach,
system 10 can deliver therapy to improve SDB such as OSA, for example, by stimulating the HGN, for example, through a shorter, less invasive procedure. The elimination of an on-board, implanted power source in favor of an inductive power scheme can eliminate the need for batteries and the associated battery changes over the patient's life. - Additionally,
stimulator 20 can implement electromyography (EMG) electrodes for sensing neuromuscular responses to physiological needs of the patient during sleep. Such sensing electrodes can continuously monitor physiological intrinsic EMG signals from the anterior lingual musculature. For instance, EMG sensing electrodes can be configured to detect neuromuscular responses from the genioglossus muscle, which is innervated by the HGN. -
Controller 100 can use transmittingantenna 112 for multiple purposes, for example: 1) to provide power tostimulator 20 during therapy sessions, and 2) to communicate with the stimulator. This communication can, for example, include programming, e.g., uploading software/firmware revisions tostimulator 20, changing/adjusting stimulation settings and/or parameters, and adjusting parameters of control algorithms.Controller 100 can receive the programming, software/firmware, and settings/parameters through any of the communication paths described above, e.g., fromuser interface 200 or through direct WiFi internet connection, when available. The communication paths can also be used to download data fromstimulator 20, such as measured data regarding completed stimulation therapy sessions, to thecontroller 100. Thecontroller 100 can transmit the downloaded data to theuser interface 200, which can send/upload the data toserver 216 viainternet 208. - In operation, sensed EMG responses from the genioglossus muscle can allow closed-loop operation of the
stimulator 20 while eliminating the need for a chest lead. Operating in closed-loop, thestimulator 20 can maintain stimulation synchronized with respiration, for example, while preserving the ability to detect and account for momentary obstruction. Thestimulator 20 can also detect and respond to snoring, for example. - To facilitate real-time, closed-loop control, a control algorithm can be implemented locally on
stimulator 20. This can be achieved, for example, by programming a control algorithm on an application-specific integrated circuit (ASIC) component of stimulator 20 (see below for the description of the stimulator electronics). - Operating in real-time,
stimulator 20 can record data related to the stimulation session including, for example, stimulation settings, EMG responses, respiration, sleep state including different stages of REM and non-REM sleep, etc. For example, changes in phasic and tonic EMG activity of genioglossus muscle during inspiration can serve as a trigger for stimulation or changes in stimulation can be made based on changes in phasic and tonic EMG activity of the genioglossus muscle during inspiration or during different sleep stages. After the sleep session, this recorded data can be uploaded touser interface 200 and toserver 216. Also, the patient can be queried to use theinterface 200 to log data regarding their perceived quality of sleep, which can also be uploaded to theserver 216. Offline, theserver 216 can execute a software application to evaluate the recorded data to determine whether settings and control parameters can be adjusted to further optimize the stimulation therapy. The software application can, for example, include artificial intelligence (AI) models that, learn from recorded therapy sessions, how certain adjustments affect the therapeutic outcome for the patient. In this manner, through AI learning, the model can provide patient-specific optimized therapy. - The stimulator can have a variety of configurations, which can be tailored to the specific therapy being applied and/or to the anatomy at the site at which the stimulation therapy is applied. An example configuration of the
stimulator 20 is illustrated inFIG. 2 .Stimulator 20 can includepower receiver 30,electronics package 50, andstimulator lead 80.Power receiver 30 can include acoiled receiver antenna 32 that is packaged in a protective biocompatible material and is operatively connected to theelectronics package 50 andelectronic components 52 mounted therein. - The
stimulator lead 80 is also operatively connected to theelectronics package 50, which controls the operation of theelectrodes 82. In the example configuration of the present disclosure,stimulator 20 includespigtail connector 54, which extends fromelectronics package 50 and can facilitate connectingstimulator lead 80 to the electronics package.Pigtail connector 54 can facilitate a detachable connection betweenelectronics package 50 and stimulator lead 80 so that leads of different configurations can be connected to the electronics package. This can facilitate manufacturing of thestimulator lead 80. This can also allow a physician to select a lead having a desired size and/or configuration. - Additionally, the
stimulator lead 80 being separate from, and connectable to, the remainder of thestimulator 20 via thepigtail connector 54, can facilitate implanting the lead separately. As a result, implanting thelead 80 can be much less invasive, allowing the lead to be placed via a small incision. An integrated design could necessitate a larger incision and also the need to handle and manipulate theentire stimulator 20 as a whole during the implantation process, which could complicate the lead placement, as the surgeon could have to work around the remainder of thestimulator 20, e.g., theelectronics package 50 and theantenna 32. -
Stimulator lead 80 can be generally elongated and includes a plurality ofelectrodes 82 spaced along its length.Electrodes 82 can be electrically connected toelectronics package 50 by conductors, such as wires, that are illustrated schematically at 84 by dashed lines inFIG. 2 . In the example configuration illustrated inFIG. 2 ,stimulator 20 has an eight-channel, eight electrode configuration, meaning thatstimulator lead 80 includes eightelectrodes 82, each having its own dedicated channel.Stimulator 20 can be configured to have a greater number of channels or fewer channels. Additionally or alternatively, stimulator 20 can include more than one lead, again depending on the specific therapy and/or the targeted anatomical structure. Regardless of the number of leads or channels, eachelectrode 82 can be configured and utilized independently of the other electrodes. Because of this, all or some ofelectrodes 82, whichever is determined to be most effective for a particular implementation, can be utilized during the application of stimulation therapy. -
Electrodes 82 can be utilized as stimulating electrodes or sensing electrodes. Stimulating electrodes can used to apply stimulation to a target anatomical structure, such as, for example, a nerve or muscle. Sensing electrodes can be used to detect and measure an EMG response, for example, from a neuromuscular structure associated with the target nerve. For a SDB treatment implementation illustrated in this description, the target nerve can be the HGN and the associated muscle can be the genioglossus muscle. The stimulator can, however, be used to target other nerves and to measure physiological electrical signals from other anatomical structures, such as EMG responses, from other neuromuscular structures. - In the example configuration of
FIG. 2 ,electrodes 82 are arranged in two groups of four electrodes spaced along the length oflead 80. One group ofelectrodes 82 can be positioned distally near an end oflead 80 and one group can be positioned proximally, between the distal group andelectronics package 50. The configuration ofelectrodes 82 can, however, vary. The stimulator can include a different number of electrodes (two or more), and/or the electrodes can be grouped, spaced, or otherwise arranged in different configurations along the length of the lead. As mentioned previously, the stimulator can also include any suitable number of leads (one or more). - The identities of
electrodes 82 as being stimulation electrodes or sensing electrodes can be determined by the manner in which they are controlled viaelectronics package 50. In certain implementations, the identities ofelectrodes 82 can be fixed. In a fixed implementation, certain ones ofelectrodes 82 can be assigned and used exclusively as stimulating electrodes and others can be assigned and used exclusively as sensing electrodes. In other implementations, the identities ofelectrodes 82 can be dynamic. In a dynamic implementation,electrodes 82 can be assigned and used as both stimulating and sensing electrodes. In further implementations,electrodes 82 can be implemented in combinations of fixed and variable identities. - How the electrodes are utilized depends at least in part on how the stimulator itself is implemented. In certain implementations of the stimulator, some or all of the electrodes can be positioned relative to structures, such as nerves and/or muscles for which both the application of stimulation energy and the sensing of an EMG response or other physiological electrical signal is desired. In these cases, some or all of the electrodes can be utilized as stimulating electrodes when stimulation at its location is desired, and as sensing electrodes when sensing at its location is desired. In other implementations of the stimulator, some electrodes can be positioned relative to structures for which only the application of stimulation energy is desired, and other electrodes might be positioned relative to structures for which only the sensing of EMG responses or other physiological signals is desired.
- Advantageously, the identities of
electrodes 82 is configured in software settings, and requires no hardware configurations. The selectable configurations ofelectrodes 82 can be facilitated byelectronic components 52 enclosed inelectronics package 50.Electronic components 52 are preferably implemented in an application-specific integrated circuit (ASIC). Theelectronic components 52 can, however, include one or more ASICs, discrete electronic components, and electrical connectors for connecting the electronic components topower receiver 30 and/orelectrode lead 80. The electronic components, whether embodied in a single ASIC or one or more components, can, for example, include processing and memory components, e.g., microcomputers or computers-on-a-chip, charge storage devices (e.g., capacitors) for accumulating a charge and supplying stimulation power, and solid state switching devices for selecting the identities of the electrodes (e.g., anode, cathode, recording electrode) and modulating power supplied to the electrodes (e.g., pulse-width modulation (PWM) switches). - To provide comfort to the patient and ease of insertion for physicians, the
stimulator 20 can have a generally soft/flexible construction. This soft/flexible construction can apply to lead 80,power receiver 30, or both the lead and the power receiver. In one example configuration, the stimulator components—power receiver 30,electronics package 50, and lead 80—can be coated or otherwise encased simultaneously in a single operation, such as an insert molding with a biocompatible material, such as silicone, epoxy, and various suitable polymers. - Referring to
FIGS. 4-6 ,power receiver 30 and lead 80 can have a flexible configuration that allows either or both structures to bend or flex, which facilitates implantation compatibility with a variety of anatomical structures.Power receiver 30, can be generally flat and planar in configuration, and can bend in directions transverse to its plane which, as shown inFIGS. 4-6 , is the X-Y plane.Power receiver 30 can thus bend in the Z-direction as shown in dashed lines at 30′ in the Figures.Lead 80, can be generally elongated in configuration and can extend axially, along the X-axis as shown inFIGS. 4-6 .Lead 80 can bend in multiple directions relative to that plane, i.e., in the direction of one or both of the Y-direction and Z-direction, as shown in dashed lines at 80′ in the figures. - To facilitate the flexible configuration of
lead 80,electrodes 82 and the conductors 84 (seeFIG. 2 ) that connect the electrodes to theelectronics package 50 can be encased and supported in acovering 86. Covering 86 can be formed of a biocompatible material, such as silicone and various suitable polymers, and can be configured to leave exposedelectrodes 82 or portions thereof. Covering 86 can be formed, for example, in the aforementioned insert molded covering of thestimulator 20 structure. - To facilitate the flexible configuration of
power receiver 30,antenna 32 can be formed on a soft substrate so as to be flexible and conform to the anatomy at the site of implantation. For example,power receiver 30 can have a flexible printed circuit board (PCB) construction in whichantenna 32 is etched from a thin layer of conductive metal laminated on a substrate 38 (seeFIG. 3 ) constructed of a flexible material, such as a polymer. In one particular flexible PCB construction, the substrate can be a polyimide material and the conductive metal can be copper. Other flexible PCB constructions can be implemented.Antenna 32 can be encased and supported in covering 48. Covering 48 can be formed of a biocompatible material, such as silicone, epoxy and various suitable polymers. Covering 48 can be formed, for example, in the aforementioned insert molded covering of theentire stimulator 20 structure. - The flexible PCB of
power receiver 30 can extend intoelectronics package 50 and can be configured to mount theelectronic components 52. The PCB can also be configured to interfaceconductors 84 oflead 80, and/or to form portions of the lead itself. In this instance,power receiver 30,electronics package 50, and lead 80 (or portions thereof) can be encased in the biocompatible material (e.g., silicone, epoxy and various suitable polymers) simultaneously. - While being flexible, the lead can also be configured to maintain a shape to which it is formed. This feature can, for example, be facilitated by
conductors 84 that connectelectrodes 82 toelectronics package 50 or by an additional internal shape-maintaining (e.g., metal) support structure (not shown) that extends along its length. In either case,metal conductors 84 or the support structure can be selected or otherwise configured to possess physical properties, such as malleability/ductility, that allow the lead to be manipulated three dimensionally (3-D) into a desired shape or have a pre-determined bias and to maintain that shape or bias once formed. For example, the lead can be biased to have a certain shape that is created, for example, by heat shaping, material shaping or using other methods of manufacturing a biased lead. -
FIGS. 7-8 illustrate one such 3-D shape to which thelead 80 can be formed. The example configuration ofFIGS. 7-8 shows thelead 80 formed three-dimensionally in a generally U-Shape or omega-shape, as shown in the plan view ofFIG. 7 , with an additional or alternative bend depth-wise as shown inFIG. 8 . This particular 3-D configuration can be implemented to position theelectrodes 82 at different positions along the HGN, where the stimulator is configured to treat SDB, such as OSA, for example. More specifically, the configuration of thelead 80 inFIGS. 7 and 8 can allow for the right and left electrodes 82 (as viewed inFIG. 7 ) to be placed in very close proximity to the HGN branches. The right and leftelectrodes 82 in an implanted configuration can extend along the posterior-anterior course of the HGN, placing the electrodes at or near the location of the branch points, such as distal branch points from the main trunk. This placement allows for direct electrical activation of a single branch or branches as needed for control of the posterior airway. In addition, with this implementation oflead 80,neurostimulation system 10 can be configured to stimulate bilaterally or unilaterally as needed without unnecessary or unwanted stimulation of surrounding structures. Because of the 3-D biased nature of thelead 80 and the synchronous manner in which the anterior lingual muscle move, additional anchoring structures may be unnecessary. For example, the inferior bend of the intermediate portion of the lead relative to the left and right electrode sets 82 when the stimulator is fully deployed can allow for force to be exerted against the genioglossus muscle by the lead, since the genioglossus muscle has a convex shape (when viewed inferiorly) to allow for better contact between the electrode sets and the genioglossus muscle - The power receiver is designed with the goal of delivering maximum power to the stimulator from a given external magnetic field. With this goal in mind, for the HGN stimulation implementation of the example configuration disclosed herein, power receiver and receiving antenna have a unique configuration designed to adhere to several criteria for stimulator. The criteria depend, of course, on the intended therapeutic use of the system and the configuration resulting therefrom. The criteria set forth below are specific to an example configuration of system for treating SDB including OSA via neuromodulation of the HGN:
- The
stimulator 20 operates within the guidelines for maximum permissible magnetic field exposure as recommended in IEEE Standard C95.1-2005 (Reference 3). - The receiving
antenna 32 allows for near continuous power consumption (10-30 milliwatts (mW)) from thestimulator 20. - The receiving antenna operates at a frequency ranging from 100 kHz to 2.4 GHz ISM (industrial, scientific, medical band of the radiofrequency spectrum). In one particular implementation, frequencies of 6.78 MHz or 13.56 MHz were used.
- The receiving
antenna 32 has a diameter of 2-3 cm. and be as thin as possible to maintain flexibility. - The
stimulator 20 is small enough for minimally invasive subcutaneous implantation within the soft tissue of the sub-maxillary neck. - The
stimulator 20 maintains a soft, flexible design so that it can be manipulated to conform to the anatomy of the patient. Other stimulation therapies or implementations of theimplantable stimulation system 10 can cause some or all of these criteria to be changed or adjusted, and also for certain criteria to be added or removed. - To meet these criteria, receiving
antenna 32 can have a double-layer, flat, “pancake” configuration. Referring toFIG. 3 ,antenna 32 can have a flexible PCB construction in which first or upper/top antenna coil 34 is formed on a first or upper/top side ofsubstrate 38 and second or lower/bottom antenna coil 36 is formed on a second or lower/bottom side of the substrate.Substrate 38 can be a thin (e.g., 1 to 3 mil) polyimide layer and coils 34, 36 can be etched from thin layers of copper or gold (e.g., 1 oz./ft2≈1.4 mil) laminated ontosubstrate 38. -
PCB 38 can also supportelectronic components 52 inelectronics package 50. Using guidelines for maximum permissible magnetic field exposure, IEEE Standard C95.1-2005 (which is incorporated herein by reference in its entirety), the maximum achievable delivered power is approximately 10-30 mW at 6.78 MHz frequency. These power requirements were chosen based on the estimated requirements forcomponents 52 ofelectronics package 50, the estimated maximum stimulation parameters, and pre-clinical studies, while also including a safety factor to allow for capacitor charging and to provide transitional power. Transitional power can be provided via a variety of components, such as capacitors, supercapacitors, ultracapacitors, or even a rechargeable power source, such as a battery. Continuous power during patient movement, especially at the high end of power ratios and/or when coupling is not ideal. The transitional power source helps ensure complete, continuous operation of thestimulator 20, even during patient movement. - Those skilled in the art will appreciate that, in operation, an antenna can be susceptible to power losses due to substrate losses and parasitic capacitance between
coils - Advantageously,
antenna 32 can implement a unique two-layer, pancake style coil configuration in which coils 34, 36 are configured in parallel. As a result, coils 34, 36 can generate an equal or substantially equal induced voltage potential when subjected to an electromagnetic field. This can help to equalize the voltage ofcoils antenna 32. In this parallel coil configuration ofantenna 32, top andbottom coils - This improved, parallel configuration of antenna is illustrated in, which illustrate the top and bottom coils and, respectively, on PCB substrate. Each coil, can include a plurality of coil windings or turns and can be characterized by the following properties: number of turns (N), outside diameter (OD), coil pitch (P), trace width (W), trace thickness (T), and coil spacing (S). These properties are measured as follows:
- The OD is the diameter of
coil outermost turn 40. - The coil pitch P is the spacing between turns 40 measured between any two adjacent turns.
- The coil width W is the width of each
coil turn 40. - The trace thickness T is the thickness of
turns 40, which is determined by the thickness of the conductive (Cu) layers laminated ontosubstrate 38 in the PCB construction. - The coil spacing S is the distance between
coils substrate 38 in the PCB construction. - In one particular configuration of
antenna 32,PCB substrate 38 is a 2 mil polyimide layer and coils 34, 36 are etched from 1.4 mil copper laminated onto the substrate. The parallel coil configuration of theantenna 32 results from electrically connecting theturns 40 of thecoils substrate 38. These connections can be in the form of electrically conductive connectors illustrated at 42 inFIGS. 9A and 9B .Connectors 42 between theturns 40 can, for example, be formed by drilling or laser etching holes through the PCB structure, e.g., throughsubstrate 38 and turns 40 of the upper andlower coils -
Coils antenna 32 have a unique configuration that allows for their parallel interconnection. On each side ofantenna 32, turns 40 are circular, each having a fixed diameter with closely spaced ends. This is opposed to a traditional coil configuration in which the diameter of the turns varies continuously in a spiral that decreases progressively from outside to inside. To create the coiled configuration of theantenna 32, on one side of the antenna (upper coil 34 side in the example configuration ofFIG. 9A ), links 44 can extend diagonally betweenadjacent turns 40 ofupper coil 34.Links 44 can be formed as portions of the copper layer, for example, laminated ontosubstrate 38, and therefore can be formed coextensively withturns 40 ofupper coil 34 as one continuous conductive (Cu) strip.Upper coil 34 can therefore be configured as a continuous coil having decreasing diameter from outside to inside and can therefore function as a spirally configured coil. - On the
lower coil 36 side ofantenna 32, turns 40 can also be circular, each having a fixed diameter with closely spaced ends. There can be no links connectingadjacent turns 40 oflower coil 36. Instead, on thelower coil 36 side ofantenna 32,terminals 46 can be formed—one connected to a terminal end of the innermost turn of the lower coil, and one connected to a terminal end of the outermost turn of the lower coil.Terminals 46 can be connected toinnermost turn 40 and can extend in the space between the ends of the remaining turns. - Viewing
FIGS. 9A and 9B , turns 40 of upper andlower coils connectors 42. Throughconnectors 42, thelinks 44 interconnecting the adjacent turns 40 of theupper coil 34 can also interconnect the adjacent turns oflower coil 36. Thus, turns 40 of thelower coil 36 also can be arranged in a continuous coiled configuration throughconnectors 42 and links 44.Lower coil 36 therefore can be configured as a continuous coil having decreasing diameter from outside to inside and can therefore function as a spirally configured coil. -
Terminals 46 can be electrically connected to bothupper coil 34 andlower coil 36 throughconnectors 42. The terminal ends from whichterminals 46 extend can be radially opposite ends of inner and outer turns 40. As shown,terminal 46 ofinnermost turn 40 is connected to a first end of the turn, on a first side of the space between the opposite ends of the turns; whereas the terminal ofoutermost turn 40 is connected to an opposite second end of the turn, on an opposite second side of the space between the opposite ends of the turns. - For the configuration illustrated in
FIGS. 9A and 9B , the performance of the antenna can depend on the properties listed above. Example configurations of the antenna, for which some of these properties were adjusted, were tested. These example configurations are illustrated in the following table: -
Property Example 1 Example 2 Example 3 Example 4 Outer Diameter (OD) 30 mm 30 mm 30 mm 26 mm # Turns (N) 12 10 8 10 Coil Pitch (P) 1.0 mm 1.0 mm 1.0 mm 1.0 mm Trace Width (W) 0.5 mm 0.5 mm 0.5 mm 0.5 mm Trace Thickness (T) 1.4 mil 1.4 mil 1.4 mil 1.4 mil Coil Spacing (S) 2 mil 2 mil 2 mil 2 mil Max. Power Delivery 32.0 mW 39.4 mW 43.7 mW 23.3 mW - As shown in the above table, the maximum power delivered provided by each example coil configuration met or exceeded the 10-30 mW power requirement, even with the reduced coil outside diameter of Example 4.
- The
external controller 100 can have two components:power mat 110 andbedside control unit 120.Control unit 120 can be connected topower mat 110 by wire, for example, and is designed to be placed bedside, e.g., on a nightstand. The control unit can include a user interface, e.g., buttons, knobs, touchscreen, etc., to allow the user to control operation of the system when using the system in bed.Power mat 110 can be designed to be placed on the sleeping surface, such as a bed mattress, and therefore can be configured to have the form of a pad, e.g., a thin, flat, soft, flexible and non-slip configuration.Power mat 110 supports one or more wireless power transmit coils 112 in or on a flexible orsemi-flexible surface 114.Power mat 110 can be positioned on the sleeping surface so that alower edge 116 of the mat corresponds approximately to the position of the patient's shoulders while sleeping. The shape and size of thepower mat 110 can correspond, for example, to that of a pillow, such as a queen size pillow. -
Control unit 120 can excite power transmitcoils 112 to generate an electromagnetic field.External controller 100 can utilize transmitcoils 112 inpower mat 110 to provide tethered wireless power transfer to stimulator 20 by way of receivingantenna 32 through electromagnetic induction. When the patient is in the sleeping position on the sleeping surface,antenna 32 ofstimulator 20 can be positioned within the electromagnetic field produced by transmitcoils 112 ofpower mat 110. The shape of the field can be tailored through the configuration of thecoils 112 to provide a field that is optimized for powering thestimulator 20 through various sleeping positions. For example, the field can be configured extend horizontally (as viewed inFIGS. 10A-C ) between thecoils 112, so that thestimulator 20 can be powered any time it is positioned within the vertical bounds of the horizontally extending field. - Through induction, electric current can be induced in receiving
antenna 32 and that current can be provided tostimulator electronics package 50.Components 52 inelectronics package 50 control the operation ofelectrodes 82. Through this operation,electrodes 82 can be utilized as stimulating electrodes for applying electrical stimulation to nerves or muscles, for example; as EMG sensing electrodes, for example, for detecting a neuromuscular response, to the application of electrical stimulation; or as both stimulation and sensing electrodes at different times during the application of stimulation therapy. - In addition to providing power to
stimulator 20,external controller 100 can also provide a data link for facilitating two-way communication between the controller and the stimulator. While powering the stimulator,controller 100 can simultaneously provide a wireless data signal that is used to program the stimulator with settings, such as electrode assignments and stimulation parameters, and also retrieve stored data from the stimulator, such as triggered stimulation events, measured EMG responses or other electrical physiological signals, current values, electrode impedances, and data related to the wireless power transfer betweencontroller 100 andstimulator 20. - Additionally, the
stimulator 20 can monitor the impedance and/or voltage of thestimulator antenna 32 so that the power supplied to the stimulator can be calculated. This can be provided as feedback to thecontroller 100 that allows the controller to adjust the current supplied to the power transmit coils 112. Thecontroller 100 can control the power delivered to the stimulator so as to remain within the standards/requirements set forth above. At the same time, the feedback can also facilitate increasing the current supplied to the power transmit coils 112 so that adequate power transfer to thestimulator 20 is maintained, again within the prescribed limits. In this manner, thecontroller 100 can implement closed-loop control to optimize the power supplied to thestimulator 20. - The operation of the
controller 100 can be controlled through theuser interface 200, which allows the user, e.g., the patient, physician or other caretaker, to control aspects of the operation of theimplantable stimulation system 10. The control can be local, e.g., by the patient using a user interface of thecontrol unit 120 or thepatient user interface 200, or remote, e.g., by the physician through internet/cloud 208. Thecontrol unit 120 can have a small footprint andpower mat 110 can be flexible in design so thatexternal controller 100 is small, discreet, and portable for travel purposes. - To account for varying sleeping positions throughout the night,
power mat 110 can have a large enough footprint to allow patient movement while still maintaining the ability to transmit power tostimulator 20. At the same time,external controller 100 does produce electromagnetic radiation at a level that falls outside the guidelines for maximum permissible magnetic field exposure as recommended in IEEE Standard C95.1-2005 (Reference 3). - Example transmit coil configurations that can be implemented in
power mat 110 are illustrated inFIGS. 10A-10C . These example transmit coil configurations can be implemented with a flex circuit design, i.e., the coils can be formed (e.g., etched) from a conductive metal (e.g., copper or gold) laminated on a flexible substrate (e.g., polyimide). The examples ofFIGS. 10A-10C illustrate the overall shape of transmitcoils 112 without showing the individual turns of the transmit coils. This is because the properties of the transmitcoils 112, e.g., the number of turns, coil pitch/spacing, trace width, etc. is not limited, as can be the case withcoils antenna 32. Antenna coils 34, 36 can be tailored specifically for maximum induced power generation due to the small footprint limitations ofantenna 32 ofstimulator 20.Power mat 110 can be larger in comparison and transmitcoils 112 can be free to be configured to produce a magnetic field that can be limited only by requiring a level that falls within the IEEE magnetic field exposure guidelines mentioned previously. - Accordingly, transmit
coils 112 can be configured to maximize the space or volume that the magnetic field covers so as to allow for variations in the patient position during sleep. This can give the system the ability to continuously power the stimulator through a variety of sleeping positions throughout the night.FIG. 10A shows a twelve coil example configuration of transmitcoils 112;FIG. 10B shows a two coil example configuration of transmit coils; andFIG. 100 shows a four coil example configuration of transmit coils. For all of these example configurations, experimental testing showed that transmit coils 112 are capable of meeting the system power requirements, within the IEEE exposure guidelines, while allowing for consistent power transfer to theantenna 32 over an effective volume of approximately 32×76×25 cm (L×W×H), which was found to be sufficient to cover the patient during a normal sleep cycle. - The twelve coil configuration of transmit
coils 112 inFIG. 10A can allow for dynamic control of the magnetic field produced by thepower mat 110. Through data coupling and communication betweenexternal controller 100 withstimulator 20, a determination can be made as to which coil(s) of the twelve coil configuration are effectuating the power coupling between the external controller and the stimulator. Through this determination, theexternal controller 100 can power only those coils necessary topower stimulator 20, given the current position of the patient relative topower mat 110. As the patient changes positions, the stimulator can detect any decrease in power transmission, which can trigger a reassessment and the selection of different coil(s). This configuration can thus be self-tuning, on-the-fly to maximize the electromagnetic field produced by thepower mat 110 in the area of theantenna 32. - The two coil configuration of the transmit
coils 112 inFIG. 10B can be static power coils that produce a continuous electromagnetic field aroundpower mat 110. This configuration can be tuned to maximize the electromagnetic field strength in the largest possible volume so that power transmission is maximized throughout a wide variety of patient positions. - In the example configurations of both
FIG. 10A andFIG. 10B ,power mat 110 can have a flexible construction facilitated by a flexible circuit construction of transmitcoils 112 housed within a flexible cover, such as, for example, soft plastic, rubber, fabric, etc. Transmit coils 112 can, for example, have a flexible PCB construction similar toantenna 32 ofstimulator 20. For instance, transmitcoils 112 can be constructed as a single layer flexible PCB, with conductive traces etched from copper, for example, laminated on a polyimide, for example, substrate. - Each of the disclosed aspects and embodiments of the present disclosure may be considered individually or in combination with other aspects, embodiments, and variations of the disclosure. Further, while certain features of embodiments and aspects of the present disclosure may be shown in only certain figures or otherwise described in the certain parts of the disclosure, such features can be incorporated into other embodiments and aspects shown in other figures or other parts of the disclosure. Along the same lines, certain features of embodiments and aspects of the present disclosure that are shown in certain figures or otherwise described in certain parts of the disclosure can be optional or deleted from such embodiments and aspects. Additionally, when describing a range, all points within that range are included in this disclosure. Furthermore, all references cited herein are incorporated by reference in their entirety.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/661,705 US20230024498A1 (en) | 2019-05-02 | 2022-05-02 | Implantable stimulation power receiver, systems and methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962841978P | 2019-05-02 | 2019-05-02 | |
US16/865,541 US11351380B2 (en) | 2019-05-02 | 2020-05-04 | Implantable stimulation power receiver, systems and methods |
US17/661,705 US20230024498A1 (en) | 2019-05-02 | 2022-05-02 | Implantable stimulation power receiver, systems and methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/865,541 Continuation US11351380B2 (en) | 2019-05-02 | 2020-05-04 | Implantable stimulation power receiver, systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230024498A1 true US20230024498A1 (en) | 2023-01-26 |
Family
ID=70861545
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/866,523 Active 2040-09-07 US11291842B2 (en) | 2019-05-02 | 2020-05-04 | Systems and methods for improving sleep disordered breathing |
US16/866,488 Active 2040-05-08 US11420063B2 (en) | 2019-05-02 | 2020-05-04 | Systems and methods to improve sleep disordered breathing using closed-loop feedback |
US16/865,541 Active US11351380B2 (en) | 2019-05-02 | 2020-05-04 | Implantable stimulation power receiver, systems and methods |
US17/654,451 Pending US20220266030A1 (en) | 2019-05-02 | 2022-03-11 | Systems and methods for improving sleep disordered breathing |
US17/661,705 Pending US20230024498A1 (en) | 2019-05-02 | 2022-05-02 | Implantable stimulation power receiver, systems and methods |
US17/817,192 Active US11869211B2 (en) | 2019-05-02 | 2022-08-03 | Systems and methods to improve sleep disordered breathing using closed-loop feedback |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/866,523 Active 2040-09-07 US11291842B2 (en) | 2019-05-02 | 2020-05-04 | Systems and methods for improving sleep disordered breathing |
US16/866,488 Active 2040-05-08 US11420063B2 (en) | 2019-05-02 | 2020-05-04 | Systems and methods to improve sleep disordered breathing using closed-loop feedback |
US16/865,541 Active US11351380B2 (en) | 2019-05-02 | 2020-05-04 | Implantable stimulation power receiver, systems and methods |
US17/654,451 Pending US20220266030A1 (en) | 2019-05-02 | 2022-03-11 | Systems and methods for improving sleep disordered breathing |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/817,192 Active US11869211B2 (en) | 2019-05-02 | 2022-08-03 | Systems and methods to improve sleep disordered breathing using closed-loop feedback |
Country Status (8)
Country | Link |
---|---|
US (6) | US11291842B2 (en) |
EP (5) | EP3962592B1 (en) |
JP (2) | JP2022531411A (en) |
CN (3) | CN117122791A (en) |
AU (2) | AU2020264530A1 (en) |
CA (2) | CA3138870A1 (en) |
ES (2) | ES2955341T3 (en) |
WO (3) | WO2020223723A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11869211B2 (en) | 2019-05-02 | 2024-01-09 | Xii Medical, Inc. | Systems and methods to improve sleep disordered breathing using closed-loop feedback |
US11883667B2 (en) | 2019-10-15 | 2024-01-30 | Xii Medical, Inc. | Biased neuromodulation lead and method of using same |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3637432B1 (en) * | 2018-09-21 | 2022-03-23 | Tata Consultancy Services Limited | System and method for non-apnea sleep arousal detection |
GB2573028B (en) | 2018-10-17 | 2020-04-29 | Signifier Medical Tech Limited | Oral muscle training |
US20200281522A1 (en) | 2019-03-06 | 2020-09-10 | Medtronic Xomed, LLC | System and method for improved obstructive sleep apnea diagnostic for implantable devices |
WO2021076662A1 (en) | 2019-10-16 | 2021-04-22 | Invicta Medical, Inc. | Adjustable devices for treating sleep apnea, and associated systems and methods |
US11623086B2 (en) | 2020-01-24 | 2023-04-11 | Medtronic Xomed, Inc. | System and method for therapy |
US11666755B2 (en) | 2020-01-24 | 2023-06-06 | Medtronic Xomed, Inc. | System and method for therapy |
US11819233B2 (en) | 2020-01-24 | 2023-11-21 | Medtronic Xomed, Inc. | Devices and techniques for separating tissue |
US11426201B2 (en) | 2020-01-24 | 2022-08-30 | Medtronic Xomed, Inc. | Treatment of obstructive sleep apnea (OSA) |
US11273305B2 (en) | 2020-01-24 | 2022-03-15 | Medtronic Xomed, Inc. | Medical lead for treating obstructive sleep apnea (OSA) with electrical stimulation |
US11464977B2 (en) | 2020-03-23 | 2022-10-11 | Medtronic, Inc. | Obstructive and central sleep apnea combination therapy control |
US11666270B2 (en) | 2020-04-30 | 2023-06-06 | Medtronic Xomed, Inc. | Personalized and contextualized treatment of sleep apnea and obesity comorbidity |
US11862312B2 (en) | 2020-08-21 | 2024-01-02 | Stimscience Inc. | Systems, methods, and devices for sleep intervention quality assessment |
US20220059208A1 (en) * | 2020-08-21 | 2022-02-24 | Stimscience Inc. | Systems, methods, and devices for sleep intervention quality estimation |
US20220134102A1 (en) | 2020-11-04 | 2022-05-05 | Invicta Medical, Inc. | Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods |
GB202018997D0 (en) * | 2020-12-02 | 2021-01-13 | Signifier Medical Tech Limited | Oral muscle composition detection and training |
US11666271B2 (en) | 2020-12-09 | 2023-06-06 | Medtronic, Inc. | Detection and monitoring of sleep apnea conditions |
US11691010B2 (en) | 2021-01-13 | 2023-07-04 | Xii Medical, Inc. | Systems and methods for improving sleep disordered breathing |
US20240100343A1 (en) * | 2021-08-24 | 2024-03-28 | Avivomed, Inc. | Cranial nerve stimulator with therapeutic feedback |
US11925804B2 (en) | 2021-11-03 | 2024-03-12 | Medtronic Xomed, LLC | Multi-device obstructive sleep apnea (OSA) treatment |
CN114391808A (en) * | 2021-12-23 | 2022-04-26 | 山东师范大学 | Sleep staging method and system based on nonlinear interdependency |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8204602B2 (en) * | 2008-04-23 | 2012-06-19 | Medtronic, Inc. | Recharge system and method for deep or angled devices |
US20140266933A1 (en) * | 2013-03-14 | 2014-09-18 | Neuropace, Inc. | Anatomically compliant antenna for implantable medical device |
US20150088025A1 (en) * | 2012-05-01 | 2015-03-26 | Advanced Bionics Ag | Electromyography response detection systems and methods |
US20160094082A1 (en) * | 2013-05-13 | 2016-03-31 | Nitto Denko Corporation | Coil printed circuit board, power reception module, battery unit and power reception communication module |
US20180221673A1 (en) * | 2017-02-07 | 2018-08-09 | Advanced Bionics Ag | Antenna apparatus for use with medical implants |
US11351380B2 (en) * | 2019-05-02 | 2022-06-07 | Xii Medical, Inc. | Implantable stimulation power receiver, systems and methods |
Family Cites Families (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US910774A (en) | 1908-05-09 | 1909-01-26 | Ezra D Beers | Replanting attachment for cultivators. |
US4990160A (en) | 1988-02-16 | 1991-02-05 | Edward Terino | Extended chin and mandible implants |
US5335657A (en) * | 1991-05-03 | 1994-08-09 | Cyberonics, Inc. | Therapeutic treatment of sleep disorder by nerve stimulation |
US5522862A (en) * | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
US5591216A (en) | 1995-05-19 | 1997-01-07 | Medtronic, Inc. | Method for treatment of sleep apnea by electrical stimulation |
US5609621A (en) | 1995-08-04 | 1997-03-11 | Medtronic, Inc. | Right ventricular outflow tract defibrillation lead |
US6198970B1 (en) | 1995-10-27 | 2001-03-06 | Esd Limited Liability Company | Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation |
FR2745946B1 (en) | 1996-03-08 | 1998-04-17 | Schneider Electric Sa | ELECTRIC VACUUM BREAKER OR CIRCUIT BREAKER |
US5716377A (en) | 1996-04-25 | 1998-02-10 | Medtronic, Inc. | Method of treating movement disorders by brain stimulation |
US5988171A (en) | 1997-06-26 | 1999-11-23 | Influence Medical Technologies, Ltd. | Methods and devices for the treatment of airway obstruction, sleep apnea and snoring |
WO1999020339A1 (en) | 1997-10-17 | 1999-04-29 | Respironics, Inc. | Muscle stimulating device and method for diagnosing and treating a breathing disorder |
US6587725B1 (en) | 1998-07-27 | 2003-07-01 | Dominique Durand | Method and apparatus for closed-loop stimulation of the hypoglossal nerve in human patients to treat obstructive sleep apnea |
US6240316B1 (en) | 1998-08-14 | 2001-05-29 | Advanced Bionics Corporation | Implantable microstimulation system for treatment of sleep apnea |
US6212435B1 (en) | 1998-11-13 | 2001-04-03 | Respironics, Inc. | Intraoral electromuscular stimulation device and method |
US6314324B1 (en) * | 1999-05-05 | 2001-11-06 | Respironics, Inc. | Vestibular stimulation system and method |
US20040122787A1 (en) | 2002-12-18 | 2004-06-24 | Avinash Gopal B. | Enhanced computer-assisted medical data processing system and method |
US7668591B2 (en) | 2003-09-18 | 2010-02-23 | Cardiac Pacemakers, Inc. | Automatic activation of medical processes |
DE602004014281D1 (en) * | 2003-08-18 | 2008-07-17 | Cardiac Pacemakers Inc | CONTROL UNIT FOR IRREGULAR BREATHING |
US7970475B2 (en) | 2003-10-15 | 2011-06-28 | Rmx, Llc | Device and method for biasing lung volume |
US8467876B2 (en) | 2003-10-15 | 2013-06-18 | Rmx, Llc | Breathing disorder detection and therapy delivery device and method |
US10589087B2 (en) | 2003-11-26 | 2020-03-17 | Wicab, Inc. | Systems and methods for altering brain and body functions and for treating conditions and diseases of the same |
US20070239230A1 (en) | 2004-12-17 | 2007-10-11 | Medtronic, Inc. | System and method for regulating cardiac triggered therapy to the brain |
US7680538B2 (en) | 2005-03-31 | 2010-03-16 | Case Western Reserve University | Method of treating obstructive sleep apnea using electrical nerve stimulation |
US20070160273A1 (en) | 2006-01-10 | 2007-07-12 | Adi Maschiah | Device, system and method for modifying two dimensional data of a body part |
US20070160274A1 (en) | 2006-01-10 | 2007-07-12 | Adi Mashiach | System and method for segmenting structures in a series of images |
US20070263915A1 (en) | 2006-01-10 | 2007-11-15 | Adi Mashiach | System and method for segmenting structures in a series of images |
US20080260229A1 (en) | 2006-05-25 | 2008-10-23 | Adi Mashiach | System and method for segmenting structures in a series of images using non-iodine based contrast material |
US7660632B2 (en) | 2006-06-30 | 2010-02-09 | Ric Investments, Llc | Method and apparatus for hypoglossal nerve stimulation |
US20080039904A1 (en) | 2006-08-08 | 2008-02-14 | Cherik Bulkes | Intravascular implant system |
US9913982B2 (en) | 2011-01-28 | 2018-03-13 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US7809442B2 (en) | 2006-10-13 | 2010-10-05 | Apnex Medical, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9186511B2 (en) | 2006-10-13 | 2015-11-17 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9744354B2 (en) | 2008-12-31 | 2017-08-29 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9095709B2 (en) | 2006-12-22 | 2015-08-04 | Second Sight Medical Products, Inc. | Visual prosthetic apparatus for retinal stimulation |
US7937246B2 (en) | 2007-09-07 | 2011-05-03 | Board Of Regents Of The University Of Nebraska | Vertical track modulus trending |
US20080260217A1 (en) | 2007-04-23 | 2008-10-23 | Adi Mashiach | System and method for designating a boundary of a vessel in an image |
WO2009007896A2 (en) | 2007-07-06 | 2009-01-15 | Innovea Medical Ltd. | System and method for designating volumetric dimensions of vascular matter |
US7885713B2 (en) | 2007-07-11 | 2011-02-08 | Ampcare, Llc | Method and apparatus for laryngeal elevator musculature rehabilitation |
US10076655B2 (en) | 2007-09-21 | 2018-09-18 | Koninklijke Philips N.V. | Vestibular stimulation system |
WO2009048580A1 (en) | 2007-10-09 | 2009-04-16 | Imthera Medical, Inc. | Apparatus, system, and method for selective stimulation |
US7760776B2 (en) | 2007-11-02 | 2010-07-20 | Glen Ivan Redford | Scalable, reconfigurable, laser combiner |
US20090226057A1 (en) | 2008-03-04 | 2009-09-10 | Adi Mashiach | Segmentation device and method |
US9259568B2 (en) | 2008-04-29 | 2016-02-16 | Cardiac Pacemakers, Inc. | Systems and methods for delivering electric current for spinal cord stimulation |
WO2009143560A1 (en) * | 2008-05-26 | 2009-12-03 | Cochlear Limited | Additional coil for an implantable hearing aid device |
EP2296751A1 (en) | 2008-06-03 | 2011-03-23 | Medtronic, Inc. | Bifurcated lead system and apparatus |
WO2010006218A2 (en) | 2008-07-11 | 2010-01-14 | Don Headley | Sleep apnea device and method |
US8428725B2 (en) | 2008-10-09 | 2013-04-23 | Imthera Medical, Inc. | Method of stimulating a Hypoglossal nerve for controlling the position of a patient's tongue |
WO2010042055A1 (en) | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | Charger for implant |
JP5575789B2 (en) * | 2008-11-19 | 2014-08-20 | インスパイア・メディカル・システムズ・インコーポレイテッド | How to treat sleep-disordered breathing |
DK2396072T3 (en) | 2009-01-14 | 2013-04-08 | Spinal Modulation Inc | STIMULATING ELECTRODE DELIVERY SYSTEM |
EP2416845B1 (en) | 2009-03-31 | 2015-03-18 | Inspire Medical Systems, Inc. | Percutaneous access for systems of treating sleep-related disordered breathing |
US20100280568A1 (en) * | 2009-04-30 | 2010-11-04 | Cherik Bulkes | Implantable High Efficiency Energy Transfer Module With Near-Field Inductive Coupling |
JP5711221B2 (en) | 2009-05-15 | 2015-04-30 | スパイナル・モデュレーション・インコーポレイテッドSpinal Modulation Inc. | Methods, systems, and devices for neuromodulating spinal cord tissue |
CA2770151A1 (en) | 2009-08-05 | 2011-02-10 | Ndi Medical, Llc | Systems and methods for maintaining airway patency |
US9415216B2 (en) | 2009-10-20 | 2016-08-16 | Nyxoah SA | Devices for treatment of sleep apnea |
US8585617B2 (en) | 2009-12-21 | 2013-11-19 | Nyxoah SA | Diagnosis and prediction of obstructive sleep apnea |
US10806926B2 (en) | 2009-10-20 | 2020-10-20 | Man & Science Sa | Implantable electrical stimulator |
US9409013B2 (en) | 2009-10-20 | 2016-08-09 | Nyxoah SA | Method for controlling energy delivery as a function of degree of coupling |
US9849289B2 (en) | 2009-10-20 | 2017-12-26 | Nyxoah SA | Device and method for snoring detection and control |
US10751537B2 (en) | 2009-10-20 | 2020-08-25 | Nyxoah SA | Arced implant unit for modulation of nerves |
US20110112601A1 (en) | 2009-11-10 | 2011-05-12 | Imthera Medical, Inc. | System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US8983610B2 (en) | 2009-11-18 | 2015-03-17 | Case Western Reserve University | Hybrid method for modulating upper airway function in a subject |
EP2544590B1 (en) | 2010-03-12 | 2018-02-14 | Inspire Medical Systems, Inc. | System for identifying a location for nerve stimulation |
US20110230702A1 (en) | 2010-03-16 | 2011-09-22 | Kirk Honour | Device, System, And Method For Treating Sleep Apnea |
EP2629661B1 (en) | 2010-10-20 | 2016-12-14 | Koninklijke Philips N.V. | Apparatus for diagnosing obstructive sleep apnea with an awake patient |
CN103298523B (en) | 2010-11-23 | 2016-05-25 | 心脏起搏器公司 | For the folded antenna of implantable medical device |
CA2850444A1 (en) | 2011-09-30 | 2013-04-25 | Adi Mashiach | Apparatus and method to control an implant |
WO2013057597A1 (en) | 2011-10-17 | 2013-04-25 | Cordenet-Produtora De Redes Agricolas, S.A. | Knitted net for wrapping agricultural products |
JP2013208182A (en) | 2012-03-30 | 2013-10-10 | Olympus Corp | Defibrillation electrode |
EP2849838B1 (en) | 2012-05-15 | 2021-11-17 | Imthera Medical, Inc. | Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue |
CN115813368A (en) | 2012-05-30 | 2023-03-21 | 瑞思迈传感器技术有限公司 | Method and apparatus for monitoring cardiopulmonary health |
US9907967B2 (en) | 2012-07-26 | 2018-03-06 | Adi Mashiach | Transcutaneous power conveyance device |
US10052097B2 (en) | 2012-07-26 | 2018-08-21 | Nyxoah SA | Implant unit delivery tool |
US9511238B2 (en) | 2012-07-26 | 2016-12-06 | Nyxoah SA | Implant holder and suture guide |
US11253712B2 (en) | 2012-07-26 | 2022-02-22 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
US9504828B2 (en) | 2012-07-26 | 2016-11-29 | Nyxoah SA | Electrical contacts on a medical device patch |
JP6404819B2 (en) * | 2012-09-19 | 2018-10-17 | レスメッド センサー テクノロジーズ リミテッド | System and method for determining sleep stage |
DE202012009867U1 (en) | 2012-10-16 | 2012-11-26 | em-tec GmbH Werner Heinze | Coil for inductive transcutaneous transmission of high powers |
US20140135868A1 (en) | 2012-11-09 | 2014-05-15 | Jacob Bashyam Bashyam | Non-invasive intraoral electrical stimulator system and method for treatment of obstructive sleep apnea (osa) |
WO2014096973A2 (en) | 2012-12-19 | 2014-06-26 | Adi Mashiach | Systems and methods for internal analyte sensing |
US20150314126A1 (en) | 2012-12-19 | 2015-11-05 | Cephalix SA | Systems and Methods for the Treatment of Head Pain |
US10238875B2 (en) | 2012-12-19 | 2019-03-26 | Adi Mashiach | Systems and methods for hypertension control |
EP2981330A4 (en) | 2013-04-05 | 2017-01-04 | Waseem Ahmad | Devices and methods for airflow diagnosis and restoration |
CA2917532A1 (en) | 2013-06-17 | 2014-12-31 | Guy SIMAN | Implant unit delivery tool |
US9917356B2 (en) | 2013-09-13 | 2018-03-13 | Lawrence Livermore National Security, Llc | Band-notched spiral antenna |
US9387332B2 (en) | 2013-10-08 | 2016-07-12 | Medtronic, Inc. | Implantable medical devices having hollow sleeve cofire ceramic structures and methods of fabricating the same |
WO2015077283A1 (en) | 2013-11-19 | 2015-05-28 | The Cleveland Clinic Foundation | System for treating obstructive sleep apnea |
US20170143280A1 (en) | 2014-01-07 | 2017-05-25 | Invicta Medical, Inc. | Determining a type of disordered breathing |
US20170143257A1 (en) * | 2014-01-07 | 2017-05-25 | Invicta Medical, Inc. | Determining a level of compliance using a device for treatment of disordered breathing |
US20160106976A1 (en) | 2014-01-10 | 2016-04-21 | Theodore R. Kucklick | Device and method for treatment of sleep apnea |
EP4241662A1 (en) | 2014-02-11 | 2023-09-13 | Cyberonics, Inc. | Systems for detecting and treating obstructive sleep apnea |
EP3116385B1 (en) | 2014-03-14 | 2019-11-06 | Nalu Medical, Inc. | Apparatus for versatile minimally invasive neuromodulators |
US20150265221A1 (en) | 2014-03-19 | 2015-09-24 | Boston Scientific Scimed, Inc. | Methods and systems for diagnostic monitoring |
SG11201701073RA (en) | 2014-08-22 | 2017-04-27 | Fujitsu Ltd | State estimating method, state estimating system, clothing, and monitoring system |
CA2975488C (en) | 2015-02-06 | 2021-09-07 | Nalu Medical, Inc. | Medical apparatus including an implantable system and an external system |
CN106329096B (en) | 2015-06-30 | 2020-03-31 | 比亚迪股份有限公司 | NFC antenna |
US10195428B2 (en) | 2015-09-29 | 2019-02-05 | Medtronic, Inc. | Neural stimulation to treat sleep apnea |
EP4252833A3 (en) * | 2015-11-17 | 2023-11-15 | Inspire Medical Systems, Inc. | Microstimulation sleep disordered breathing (sdb) therapy device |
WO2017112960A1 (en) * | 2015-12-23 | 2017-06-29 | Invicta Medical, Inc. | Method and apparatus for predicting disordered breathing |
WO2017173433A1 (en) | 2016-04-01 | 2017-10-05 | Tholakanahalli Venkatakrishna N | Shaped epicardial lead and placement system and method |
US10470921B2 (en) | 2016-04-07 | 2019-11-12 | Achaemenid, Llc | Removable mandibular myo-stimulator |
WO2017184753A1 (en) | 2016-04-19 | 2017-10-26 | Inspire Medical Systems, Inc. | Accelerometer-based sensing for sleep disordered breathing (sdb) care |
EP4119185A1 (en) | 2016-06-10 | 2023-01-18 | Purdue Research Foundation | System for wireless recording and stimulating of bioelectric events |
WO2018017508A1 (en) | 2016-07-18 | 2018-01-25 | Peerbridge Health, Inc. | System and method for treating sleep apnea |
US10179052B2 (en) | 2016-07-28 | 2019-01-15 | Depuy Ireland Unlimited Company | Total knee implant prosthesis assembly and method |
US20180117313A1 (en) | 2016-10-31 | 2018-05-03 | The Alfred E. Mann Foundation For Scientific Research | Nerve cuff electrodes fabricated using over-molded lcp |
US10765862B2 (en) * | 2017-10-24 | 2020-09-08 | Vanderbilt University | Systems and methods for treating sleep disordered breathing |
US11771899B2 (en) | 2018-07-10 | 2023-10-03 | The Cleveland Clinic Foundation | System and method for treating obstructive sleep apnea |
US11351377B2 (en) | 2019-05-03 | 2022-06-07 | The Cleveland Clinic Foundation | Intra-oral appliances and systems |
US11420061B2 (en) | 2019-10-15 | 2022-08-23 | Xii Medical, Inc. | Biased neuromodulation lead and method of using same |
US11691010B2 (en) | 2021-01-13 | 2023-07-04 | Xii Medical, Inc. | Systems and methods for improving sleep disordered breathing |
-
2020
- 2020-05-04 EP EP20729309.3A patent/EP3962592B1/en active Active
- 2020-05-04 CN CN202310993707.6A patent/CN117122791A/en active Pending
- 2020-05-04 JP JP2021565077A patent/JP2022531411A/en active Pending
- 2020-05-04 ES ES20729318T patent/ES2955341T3/en active Active
- 2020-05-04 CN CN202080048590.9A patent/CN114051421B/en active Active
- 2020-05-04 AU AU2020264530A patent/AU2020264530A1/en active Pending
- 2020-05-04 WO PCT/US2020/031266 patent/WO2020223723A1/en unknown
- 2020-05-04 US US16/866,523 patent/US11291842B2/en active Active
- 2020-05-04 US US16/866,488 patent/US11420063B2/en active Active
- 2020-05-04 JP JP2021565717A patent/JP2022531007A/en active Pending
- 2020-05-04 CA CA3138870A patent/CA3138870A1/en active Pending
- 2020-05-04 EP EP20728849.9A patent/EP3962585A1/en active Pending
- 2020-05-04 CN CN202080048485.5A patent/CN114072193A/en active Pending
- 2020-05-04 AU AU2020266685A patent/AU2020266685A1/en active Pending
- 2020-05-04 CA CA3138871A patent/CA3138871A1/en active Pending
- 2020-05-04 US US16/865,541 patent/US11351380B2/en active Active
- 2020-05-04 WO PCT/US2020/031383 patent/WO2020223738A1/en unknown
- 2020-05-04 EP EP20729318.4A patent/EP3962593B1/en active Active
- 2020-05-04 ES ES20729309T patent/ES2956271T3/en active Active
- 2020-05-04 EP EP23189996.4A patent/EP4272644A3/en active Pending
- 2020-05-04 EP EP23187373.8A patent/EP4241690A3/en active Pending
- 2020-05-04 WO PCT/US2020/031389 patent/WO2020223740A1/en unknown
-
2022
- 2022-03-11 US US17/654,451 patent/US20220266030A1/en active Pending
- 2022-05-02 US US17/661,705 patent/US20230024498A1/en active Pending
- 2022-08-03 US US17/817,192 patent/US11869211B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8204602B2 (en) * | 2008-04-23 | 2012-06-19 | Medtronic, Inc. | Recharge system and method for deep or angled devices |
US20150088025A1 (en) * | 2012-05-01 | 2015-03-26 | Advanced Bionics Ag | Electromyography response detection systems and methods |
US20140266933A1 (en) * | 2013-03-14 | 2014-09-18 | Neuropace, Inc. | Anatomically compliant antenna for implantable medical device |
US20160094082A1 (en) * | 2013-05-13 | 2016-03-31 | Nitto Denko Corporation | Coil printed circuit board, power reception module, battery unit and power reception communication module |
US20180221673A1 (en) * | 2017-02-07 | 2018-08-09 | Advanced Bionics Ag | Antenna apparatus for use with medical implants |
US11351380B2 (en) * | 2019-05-02 | 2022-06-07 | Xii Medical, Inc. | Implantable stimulation power receiver, systems and methods |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11869211B2 (en) | 2019-05-02 | 2024-01-09 | Xii Medical, Inc. | Systems and methods to improve sleep disordered breathing using closed-loop feedback |
US11883667B2 (en) | 2019-10-15 | 2024-01-30 | Xii Medical, Inc. | Biased neuromodulation lead and method of using same |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11351380B2 (en) | Implantable stimulation power receiver, systems and methods | |
US20200406030A1 (en) | Implantable electrical stimulator | |
US11654284B2 (en) | Stimulator systems and methods for obstructive sleep apnea | |
US11691010B2 (en) | Systems and methods for improving sleep disordered breathing | |
US20240108899A1 (en) | Neuromodulation devices and associated systems and methods | |
AU2020278806B2 (en) | Method and system for electrical nerve stimulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: XII MEDICAL, INC., OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:YOUNG, STEVEN M.;REEL/FRAME:060777/0278 Effective date: 20220411 Owner name: XII MEDICAL, INC., OHIO Free format text: CHANGE OF NAME;ASSIGNOR:ENHALE MEDICAL, INC.;REEL/FRAME:061144/0465 Effective date: 20210324 Owner name: ENHALE MEDICAL, INC., OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CAPARSO, ANTHONY;NICKOLS, JOSH;REEL/FRAME:060777/0161 Effective date: 20200916 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
AS | Assignment |
Owner name: THE CLEVELAND CLINIC FOUNDATION, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PAPAY, FRANCIS A.;EMERTON, KELLY;SIGNING DATES FROM 20230512 TO 20230523;REEL/FRAME:063886/0472 Owner name: XII MEDICAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:XONDAS, INC.;REEL/FRAME:063884/0784 Effective date: 20230607 Owner name: XONDAS, INC., MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:YOUNG, STEVEN M.;REEL/FRAME:063884/0732 Effective date: 20230607 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |